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Picornaviruses are a group of human and animal pathogens capable of inflicting serious 
public health diseases and economic burdens. Treatments options through vaccines for 
prevention or antivirals to cure infection are not available for the vast majority of these 
viruses. These shortcomings, in the development of vaccines or antivirals therapeutic, are 
linked to the genetic diversity and to an incomplete understanding of the biology of these 
viruses. Despite the diverse host range, this group of positive-strand RNA viruses shares 
the same replication mechanisms, including the development of membranous structures 
(replication organelles) in the cytoplasm of infected cells. The development of these 
 
 
membranous structures, which serve as sites for the replication of the viral RNA genome, 
has been linked to the hijacking of elements of the cellular membrane metabolism 
pathways. Here we show that upon picornavirus infection, there is a specific activation of 
acyl-CoA synthetase enzymes resulting in strong import and accumulation of long chain 
fatty acids in the cytoplasm of infected cells. We show that the newly imported fatty acids 
serve as a substrate for the upregulation of phosphatidylcholine synthesis required for the 
structural development of replication organelles. In this work, we identified that acyl-CoA 
synthetase long chain 3 (ACSL3) is required for the upregulation of lipids syntheses and 
the replication of poliovirus. We have shown that the poliovirus protein 2A was required 
but not sufficient for the activation of import of long chain fatty acids in infected cells. We 
demonstrated that the fatty acid import is upregulated upon infection by diverse 
picornaviruses and that such upregulation is not dependent on activation of ER stress 
response or the autophagy pathways. In this work, we have demonstrated that 
phosphatidylcholine was required for the structural development of replication organelles. 
Phosphatidylcholine synthesis was dispensable for the production of infectious particles at 
high MOI but required at a low MOI for the protection of the replication complexes from 
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Chapter 1: Introduction 
1.1 Poliovirus history 
Poliovirus is the causative agent of poliomyelitis, a human disease characterized by 
a flaccid paralysis in its acute phase. This is an ancient disease already depicted in 
Egyptian’s art between 1580-1350 BCE, displaying a person with an atrophic leg leaning 
on a crutch to walk (105). Michael Underwood was the first physician to describe clinical 
symptoms of this disease in 1789 in children characterized by a debilitation of the lower 
extremities (36, 120). Karl Landsteiner and Erwing Popper formally identified poliovirus 
in 1908 as responsible of poliomyelitis in humans. Evidences of infantile paralysis were 
documented in the early nineteen century when an outbreak erupted in the South Atlantic 
Island of St Helena and the English town of Workshop around 1835 (7).  The disease began 
to spread in the late nineteen centuries and early twentieth centuries in Europe especially 
in Norway (>900 cases) Sweden (>1000 cases) in 1905 (7). Poliomyelitis began to manifest 
itself all over Europe especially in Vienna and Lower Austria (1908-1909), Germany 
(1909), and England and Wales (1911) (7). The first documented emergence of 
poliomyelitis in the United States (USA) was recorded in 1841 when 10 cases of 
poliomyelitis in the West Feliciana in Louisiana had been identified (7). 
Fifty years following the discovery of PV as the main agent of poliomyelitis, of the 
57000 cases of infection diagnosed, 22000 cases of paralytic forms had been identified in 
the USA by 1952 (62). A vaccine developed by Jonas Salk, tested and proven effective was 
licensed in 1955 (36, 127). The Salk vaccine, or the Inactivated Poliovirus Vaccine (IPV), 
was successful and had reduced the number of paralytic cases of poliomyelitis by more 
than 95% within five years after its introduction in the USA (102). A second vaccine, the 
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Oral (or “live”, “attenuated”) Poliovirus Vaccine (OPV), developed by Albert Sabin and 
licensed in the USA in 1961  also had proven to be effective in stopping the spread of the 
wild type PV infection (36, 127). The OPV became the preferred vaccine largely used 
around the globe because of its ability to provide a strong gastrointestinal immunity as well 
as its ease of use and manufacturing. Because of the introduction of the IPV and the OPV 
vaccines, the number of poliovirus infections sharply decreased around the globe and the 
last case of outbreak of wild type poliovirus infection in the USA was recorded in 1979.     
1.2 Pathogenesis 
Poliovirus infects mostly humans who are the natural host, non-human primates 
such as chimpanzees and old world monkeys when they are used for experimental disease, 
and transgenic mice expressing the human poliovirus receptor (127). PV is a highly 
contagious virus transmitted from person to person through ingestion of food or water 
contaminated with feces of a person shedding PV particles (105).  The incubation period, 
the time between exposure to the virus and the onset of the disease, may last 1 to 3 days 
leading to an abortive poliomyelitis or could extent between 2 to 35 days (99). Virus can 
be recovered from the blood and feces 3 to 5 days after infection (99). Poliovirus is stable 
in acid milieu, which is necessary for infection and replication in the gastrointestinal (GI) 
tract where the virus encounters low pH conditions. A determinant to poliovirus infection 
is the presence of poliovirus receptor (PVR) also named CD155 on the surface of 
permissive cells of the GI tract (126). CD155, discovered by Mendelsohn et al, is a 
transmembrane glycoprotein which mediates the attachment of PV particles on the cell 
surface (126).  Its discovery had also prompted the generation of transgenic mice 
expressing the human PVR in order to facilitate the study of PV infection on animal’s 
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model (129). Following infection, the poliovirus initially multiplies in lymphatic tissues 
such as Peyer’s patches in the small intestine or tonsils in the pharynx (45).  
The successful multiplication ultimately allows the PV to enter the bloodstream 
leading to the development of viremia in the absence of neutralizing antibodies  (112). The 
entry of PV particles in the bloodstream accelerates the propagation of the virus in non-
neural tissues such as cervical and mesenteric lymph nodes, bone marrow, liver and spleen 
(112). 95 % of poliovirus infections are either asymptomatic or may lead to an abortive 
poliomyelitis where there is a mild occurrence of symptoms due to the development of a 
minor viremia (126).  The minor viremia ends with mild symptoms such as sore throat, 
fever, gastrointestinal illness and a generalized malaise (126). The development of PV 
infection into a major viremia spreads the virus to the central nervous system (CNS) where 
it multiplies in the motor neurons of the spinal cord, the brain stem and the motor complex 
leading to muscle paralysis or the development of non-paralytic aseptic meningitis  (126). 
There are three serotypes of polioviruses, although all three serotypes are highly infectious, 
the poliovirus type 1 is responsible of 80% cases of paralysis in its severe form of infection 
(105). 
Three routes of PV entrance to the CNS following infection have been 
hypothesized: The first one is the crossing of the blood brain barrier (BBB) following the 
development of a major viremia after PV infections which allow viruses to access the CNS 
independently of poliovirus receptor (PVR) (36, 127). The second route of PV access to 
the CNS is the retrograde axonal transport through the sciatic nerve in a PVR dependent 
manner (113). The third route is the importation of poliovirus into the CNS by infected 
macrophages (36, 44). The clinical symptoms of  non-paralytic meningitis of PV infection 
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is characterized by the rigidity of the neck, back and lower limbs, and this occurs in 1-2% 
of PV infections while  paralytic cases occur in 0.1-1% of PV infected individuals (36).  
The tissue tropism of PV particles and subsequently the occurrence of the acute 
form of infection leading to meningitis and paralysis are tightly linked to the role of 
interferon and the production of neutralizing antibodies. PV infection is rapidly suppressed 
in non-neural tissues because of the strong response of the innate immune system mediated 
by type1 interferon (T1IFN). Contrary to non-neural tissues, PV infection of neural tissues 
especially in CNS is accelerated because of the weak response of the T1IFN (108).  
Buisman et al have shown that preexisting immunoglobulin A (IgA) in circulation 
controlled reinfection and shedding of PV particles and probably its absence could 
contribute to PV circulation (25).  
1.3 Poliovirus vaccines  
The development of PV vaccines was made possible by Enders J.F et al who in 
1949, propagated PV in live cells of non-neural tissues for the first time (46). Jonas Salk 
began the development of IPV vaccine in 1953 by growing all three PV serotypes in 
African green monkey (Monkey kidneys cells: Vero) cells (135, 136). These PV infected 
cells were then treated with lower doses of formaldehyde (also known as formalin) to kill 
the infectivity of viral particles while preserving the antigenic activity. The PV strains 
selected to produce the vaccine were Mahoney (type1), MEF-1 (type2) and Saukett (type3). 
The IPV, administered by intramuscular injection, induces high titers of neutralizing 
antibodies and effectively prevents the development of viremia or the acute phase of the 
disease. Although the IPV prevents pharyngeal excretion of virus (51) and it is safe for 
immunocompromised persons, it cannot stop the infection of the gut which is the major 
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route of PV transmission, induces lower intestinal immunity compared to natural infection, 
and is expensive to produce because it requires the wild type virus which can constitute a 
biohazard (83). The “killed” poliovirus vaccine was the only effective tool to combat the 
ravaging effect of PV infection until 1961 when the second PV vaccine was licensed.  
 
Many investigators at various institutions were involved in the development of a live 
attenuated PV vaccine. Among others, we can point out the laboratory of Albert Sabin at 
the children hospital center in Cincinnati, the Lederle laboratories headed by Herald Cox, 
and finally the laboratory of Hilary Kaprowski at the Wistart institute in Philadelphia. The 
live attenuated poliovirus vaccine was generated by serial passages of the virus in cell 
culture such as monkey testis, kidney and skin  at high and low multiplicity of infection 
(MOI), passage through animal host such as monkey and at suboptimal temperature (36, 
102). The live attenuated PV had to satisfy several conditions for a vaccine purpose: (i) 
ability to replicate effectively in the GI tract; (ii) inability to invade or to replicate in the 
CNS and (iii) genetic stability to withstand the pressure of replication within the human 
host without reversion to a neurovirulent phenotype (36). The OPV was developed from 
all three serotypes of PV: the type 1 also known as (Sabin1) derived from a type 1 Mahoney 
strain previously modified by Li and Schaefer, the type 2 (or Sabin 2) was isolated from a 
healthy child and shown to have low virulence and lastly the type 3 (or Sabin 3) was from 
Leon strain (82, 102). Following its early success, the OPV became the vaccine of choice 
for mass campaign of vaccination. The OPV, which mimics the natural route of infection, 
has many advantages over IPV and is more appealing to mass vaccination campaigns: it 
provides both systemic and intestinal immunity, it is easy to administer through oral 
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delivery, inexpensive to produce, and it confers herd immunity since the live virus vaccine 
is excreted in the environment. Although the OPV had become the weapon of choice for 
poliovirus eradication in many developing countries, it has significant shortcomings: this 
vaccine is not indicated for immuno-deficient or immunosuppressed individuals and, most 
importantly, the attenuated virus is genetically unstable.  
1.4 Poliovirus Eradication challenges   
The IPV and OPV vaccines have been excellent in reducing poliovirus infection 
around the globe since their introduction in 1955 and 1961 respectively. In 1988, the world 
health assembly, the legislative branch of the World Health Organization (WHO), decided 
to launch the global campaign aimed at eradication of poliovirus by the year 2000. This 
marked the beginning of the Global polio eradication initiative supported by non-
governmental agencies, the WHO and national countries around the globe. Although never 
reaching the ultimate eradication goals, this campaign significantly reduced the burden of 
poliovirus infections from ~350000 cases in 1988 to 416 cases in 2013 (WHO; 
http://www.who.int/mediacentre/factsheets/fs114/en/). At the beginning of this initiative, 
poliovirus was endemic in 125 countries around the globe, but today, Pakistan and 
Afghanistan are the only remaining countries. The campaign of poliovirus eradication has 
been largely successful in reducing cases of acute flaccid paralysis (AFP) due to poliovirus 
infection by 99% (WHO: http://www.who.int/mediacentre/factsheets/fs114/en/ ). Of the 
three serotypes, only the wild poliovirus type 2 was successfully eradicated around the 




The use of OPV as the primary tool in the eradication campaign has raised 
significant challenges. The OPV can inflict vaccine-associated paralytic poliomyelitis 
(VAPP) among vaccine recipients. Because OPV is a live virus vaccine, it can be 
transmitted from person to person and progress to a circulating vaccine-derived poliovirus 
(cVDPV). Through mutation and possibly recombination with other enteroviruses, the 
cVDPV can regain the pathogenicity of the wild type virus and its ability to cause paralytic 
disease (81). Thus, the type 1 cVDPV has been at the origin of outbreak of poliovirus 
infection on the island of Hispaniola which had been previously covered by OPV and 
certified polio-free (81).  The continued use of OPV, especially in areas declared free of 
indigenous polio through a certification of eradication, is the subject of debates giving the 
risk of reintroducing a live virus with the ability to revert to wild type. The eradication of 
the wild type polio continues to be a success around the globe and was highlighted by the 
removal of Nigeria in 2015 from the list of endemic countries. The monitoring is required 
especially in both certified areas as well as in places marked by poverty, social unrest or 









Chapter 2:  Poliovirus life cycle and genome organization 
2.1 The Picornaviridae family  
Poliovirus is a member of the Picornaviridae family of viruses. This family 
contains non-enveloped, single stranded positive RNA viruses. The name Picornaviridae, 
reflects the small size (Pico=10-12) of both the viral genome and the viral particle 
characteristics of viruses in this family (128). Picornaviruses are known to inflict human 
and animal diseases leading to serious economic and public health damages. Among the 
most notable of these viruses are poliovirus, the Foot and mouth disease (FMDV), Hepatitis 
A virus, enteroviruses 71 and D68, Coxsackie viruses and human rhinoviruses. Coxsackie 
virus B3  is believed to be associated with human diabetes and myocarditis, enteroviruses 
71 and D68 are known to inflict hand-foot-and-mouth disease and acute flaccid paralysis 
in children respectively, the Human rhinovirus A, B and C is linked to respiratory diseases  
(128). The Foot and Mouth Disease virus (FMDV) is known to inflict highly infectious 
vesicular diseases in cloven-footed animals such as cattle, sheep (85). Viruses in this family 
have served as objects of many groundbreaking studies in the field of virology. The first 
animal virus isolated was FMDV (128), poliovirus was the first RNA virus identified with 
a missing 5’ cap structure (128). The first infectious cDNA clone from an animal virus was 
developed for poliovirus, as well as the plaque assay which is a method used to quantify 
infectious viral particles (128). The Picornaviridae family contains 29 genera, and in 
addition, viruses in this family are further subdivided to more than 28 species.  The 
poliovirus is the prototype member of the Picornaviridae family of the genus Enterovirus 




2.2 Poliovirus structure 
Polioviruses particles have an icosahedral shape of around 30nm in diameter and 
lack a lipid envelop. Viral particles are highly stable and can retain their infectivity at a pH 
value of 3.0 since they have to gain access to intestine for replication. The poliovirus virion 
is composed of 60 subunits each of capsids proteins VP1, VP2, VP3 and VP4 (67). These 
capsid proteins derived from the proteolysis of the P1 domain of viral polyprotein. VP1, 
VP2, and VP3 constitute the outer structure of the virion whereas VP4 is located in the 
inner surface of the capsid (128). VP1 proteins are located around the five-fold axes (mesa) 
where there is also the presence of a deep depression (“canyon”) proven to be the binding 
site of PV receptor, while VP2 and VP3 alternate around  two and three-fold axes (53, 128). 
Beneath the canyon which is located on the viral capsid protein VP1, there is a hydrophobic 
tunnel or pocket where the sphingosine lipid is found in poliovirus type 1 and 3 virions 
(128). VP1 to -3 (with an average MW ~ 30 kDa) capsids proteins shared the same topology 
and each have eight-stranded and antiparallel β-barrels. 
 Each beta strands of capsid proteins formed a wedge like structure made up of 
antiparallel β-sheets. The VP1 to -3 capsids proteins are characterized by the presence of 
loops connecting the β-strand and the N- and C-terminal of β-barrels (128). These loops or 
amino acid decorate the surface of PV particles and confer distinctive morphology and 
constitute major sites of antigenicity (128). Antibodies capable of neutralizing PV 
infectivity are raised against these amino acids (160). The PV particles possess four major 
neutralizing antigenic sites; however there are only three unique sets of these four sites 




















Figure 2.1: Schematic representation of poliovirus structure with capsid proteins 
and viral genome (49)   
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2.3 Poliovirus genome organization  
The PV RNA genome is composed of 7.5 kilo bases (kb) of nucleotides (nt) and 
has four distinctive regions: the 5’ untranslated  region (UTR) has an internal 
ribosome entry site (IRES) structure  covalently linked to a 22 amino acid viral protein 
VPg (virion protein genome linked); a single open reading frame (ORF) encoding the viral 
polyprotein; the 3’ UTR which is highly structured and possesses a pseudoknot, and finally 
a poly(A) tract region which has about 60 adenine residues (36, 128).   
 
 
Figure 2.2: Genome organization of poliovirus (Source: courtesy of Dr George Belov) 
 
The 5’ UTR of PV is a complex structure characterized by: the presence of an 
internal ribosome entry site (IRES)  which directs the cap-independent translation of the 
viral mRNA ; a clover-leaf structure indispensable during viral RNA replication, and a 
polypyrimidine-tract of nucleotides lining upstream of the IRES structure (5). The 3’ UTR, 
an AU rich section of PV RNA, is about 72 nt long and exhibits a secondary structure 
consisting of two hairpins involved in the replication (23). The 3’ UTR serves as a template 
for the initiation of minus-strand synthesis by the replication complex (114). Another 
structural component of PV genome is the presence of a cis-acting replication element 
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(CRE). CRE, which has 61 bases, is located in the 2C coding region of PV and serves as 
















Figure 2.3: Processing of polyproteins and precursor proteins into individual 
structural and nonstructural proteins. The poliovirus has a genome of a positive-strand RNA 
of about 7500 nucleotides. The 5’ end is covalently linked to a viral protein VPg and contains the 
internal ribosome entry site (IRES). The open reading frame is divided into three domains: The P1 
domain encodes structural proteins or capsid while the P2 and P3 domains encode non-structural 
proteins required for the replication. The 3’ end contains a poly (A) tail of around 60 residues. Upon 
its released in the cytoplasm of infected cells, the viral genome is translated to yield a large 
polyprotein, which is then processed by viral proteases 2A, 3C and 3CD into protein precursors 
and individual proteins. The yellow triangles represent sites cleaved by the viral protease 2A. The 
red triangles represent sites cleaved by viral proteases 3C and 3CD. The 3CD protease cleaves 
preferentially structural proteins while 3C cleaves non-structural proteins. The white start presents 
a site of autocatalytic processing.  (Source: courtesy of Dr George Belov)     
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The ORF codes for a single large polyprotein subdivided into three domains P1, P2 
and P3. P1 is the precursor of structural proteins, while P2 and P3 are precursors to non-
structural proteins. The P1 domain is cleaved by viral protease 3CPro to yield structural 
proteins VP0 (precursor to VP2 and VP4), VP1 and VP3. The P2 domain of the polyprotein 
is cleaved to yield 2A and 2BC proteins and the 2BC is later processed to yield 2B and 2C 
proteins (137). The P3 domain is cleaved into 3AB and 3CD precursors proteins and are 
later processed into 3A, 3B (VPg), 3CPro (3C protease) and 3DPol (3D polymerase) the RNA 
dependent RNA polymerase (RDRP) (137).  
2.4 Poliovirus proteins and function 
The PV protein 2APro is a viral proteinase cleaving the newly synthesized 
polyprotein in cis at the junction between the structural precursor polyprotein P1 and non-
structural precursor polyprotein P2 during translation (114). The viral protein 2A is also 
known to inhibit protein synthesis of host cells by cleaving eIF-4G which is required for 
the initiation of the host protein synthesis (146). The 2APro protein has a chymotrypsin-like 
folding pattern with cysteine as the active site nucleophile.  
The viral protein 2B and its precursor 2BC have been associated with the membrane 
remodeling and production of membranes vesicular structures on which the synthesis of 
viral RNA takes place in infected cells (32). The presence of hydrophobic domains 
characterized by amphipathic α-helix allows both 2B and 2BC proteins to interact with or 
integrate into membranes organelles such as Golgi, ER complex and virus-induced 
membranes in PV infected cells (32). It was shown that the expression of PV 2B/2BC 
inhibits the secretion and trafficking of proteins between Golgi and the ER complex and 
lowers the Ca2+ level (6, 41, 152), induces membrane permeabilization (1) and the 
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disassembly of the Golgi complex (139). The viral protein 2C has NTPase activity (132) 
and just like 2B and its precursor 2BC, is also associated with the induction, remodeling 
and proliferation of membranous vesicles in PV infected cells (32). Structural prediction 
studies and conserved sequences analysis show that 2CATPase has amphipathic helix at its 
NH2-terminal domain, a nucleotide binding domain and a COOH-terminal zinc-binding 
domain (150). The 2CATPase protein possesses RNA binding activity and is the target of 
guanidine-HCl, an inhibitor known to block the initiation of the negative-strand RNA 
synthesis (8).  
The viral proteins 3A and its precursor 3AB are implicated in the induction and the 
proliferation of membranous structures in the cytoplasm of PV infected cells. The 
expression of PV protein 3A disrupts the cellular protein trafficking from the ER complex 
to Golgi (40, 41).  The presence of hydrophobic residues in the 3A section of the precursor 
protein 3AB mediates its association with cytoplasmic as well as PV-induced membranes 
during infection (151). The viral protein 3A specifically recruits ADP-ribosylation factor 
(arf) to membranes via the recruitment of Golgi-specific brefeldin A resistance factor 1 
(GBF1). 3AB also possesses RNA-chaperone activity, which may facilitate poliovirus 
RNA replication and support recombination between different genomes and may be 
important for pathogenesis of picornavirus infections (37, 38, 55). It was proposed that the 
precursor protein 3AB may serve as a substrate for 3D polymerase for VPg uridylylation 
(131), however other experiments suggested that other precursors proteins such as 3BC 
and 3BCD may be used preferentially (117). Following its uridylylation by the PV 
polymerase 3DPol  (118),  the VPg protein is relocated at both the 3’ end and the 5’ end to 
serve as a primer for the synthesis of both the negative- and the positive-strand RNA 
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synthesis (124). 3B (VPg) is covalently attached to the 5’ end of PV genome via a 5’ 
tyrosyluridine bond.  
The viral protein 3CPro and its precursor 3CD have protease activities. The 
precursor protein 3CD is preferentially involved in the processing of the structural 
polyprotein fragment P1 whereas 3C is responsible for most of the other polyprotein 
cleavages. Processing of cellular proteins by 3CPro and 3CD modifies intracellular 
processes such as nuclear transcription or host mRNA translation and enhances PV 
replication in infected cells. The 3CPro protein possesses an RNA binding motif and has a 
Cys-reactive proteinase active nucleophile  site with chymotrypsin-like fold (114). The 
3CD viral protein interacts with 3AB and poly(C)-binding protein 2 (PCBP2) at the 5’ 
cloverleaf structure to initiate the synthesis of minus-strand PV RNA (64, 157, 163). The 
3CD protein binds to the CRE RNA site, which serves as a template for the synthesis of 
VPg-pUpU (116). The viral protein 3DPol is the RNA-dependent RNA polymerase (RDRP) 
and catalyzes the synthesis of both the minus-strand and plus-strand of PV RNA genome. 
The 3DPol protein has 461 amino acids and the three-dimensional  “palm” subdomain 
structure is similar to other polymerases while its “thumb” and “fingers” subdomains are 
different from those of other polymerases (63). The PV protein 3DPol has RNA-binding 
properties, it relaxes the double-stranded RNA for elongation and possesses a terminal 
adenyltransferase activity (30, 48). In the course of PV replication, the viral protein 3DPol, 
along with other non-structural proteins such as 3AB, 2B and 2C, associates with the 




2.5 Poliovirus life cycle 
2.5.1 Poliovirus entry  
Endocytosis is the principal route of PV entry into the host cell.  The uptake of 
infectious PV particles is dependent on ATP, tyrosine phosphorylation of the cytoplasmic 
tail of the poliovirus receptor or actin but independent of clathrin, caveolis, 
micropinocytosis and is insensitive to microtubule polymerization inhibitors (22, 88). It 
starts with the attachment of poliovirus to the poliovirus receptor (also called PVR or 
CD155) on the surface of susceptible cells. The PVR is a transmembrane immunoglobulin-
like (Ig) protein with three extracellular Ig-like domains (100, 128). The attachment on 
viral particles occurs within the hydrophobic pocket beneath the canyon located on the PV 
surface (128). The attachment of PV particles with the receptor  triggers conformational 
changes, leading to the exposition of internal sequence of the myristoyl-VP4 and the N-
terminal sequence of the capsid protein VP1 (52). The externalization of VP4 and the 
hydrophobic N-terminal of VP1 sequences alter the structure of the virion and produce a 
particle called the “A particle”. The N-terminal sequence of VP1 is inserted into the cell 
membrane where it creates a pore, thereby facilitating the attachment of PV particles and 











Figure 2.4: Poliovirus life cycle. (Source: courtesy of Dr George Belov)  
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2.5.2 Poliovirus translation and replication  
Following delivery of the viral mRNA in the cytoplasm, the VPg-linked protein is 
detached from the genome by a host cell enzyme (4, 93, 156). The first step in the 
replication cycle of PV is the translation of the viral mRNA. The translation of PV mRNA 
is regulated by the IRES structure, the binding site of the 40S ribosomal subunits. The 40S 
ribosomal subunits are recruited at the IRES site via interaction with the complex of eIF3 
and C-terminal region of eIF4G (128). Since the PV mRNA codes for a single long ORF, 
the translation produces a long polyprotein which is processed co- and post-translationally 
by viral proteases 2APro (which cleaves the P1 and P2 junction) and 3CPro and 3CDPro into 
intermediates and mature structural and non-structural proteins. During viral proteins 
syntheses, there are also profound modifications of intracellular processes such as 
transcription of host genes, translation initiation of host proteins as well as nucleo-
cytoplasmic trafficking (43). The cellular proteins synthesizing machinery is incapacitated 
by the cleavage of the translation initiation factor eIF4G by PV protease 2APro (43).  
The PV genome serves as a template for both the translation and minus-strand RNA 
synthesis in infected cells. The translation of PV genome and the minus-strand RNA 
synthesis are two processes that cannot be carried out simultaneously (9, 54). Following 
the synthesis of sufficient amounts of viral proteins, translation is reduced and the PV 
genome serves as a template for the synthesis of negative-strand RNA. It was shown that 
a switch from translation to minus-strand RNA synthesis occurred when an RNA structure, 
locates at the 5’ end non-coding region of PV genome and next to the IRES, binds the viral 
protein 3CDPro and displaces the host poly r(C)-binding proteins (PCBP) (20). The 
translation and replication mechanisms in poliovirus infected cells are also regulated by 
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the cleavage of PCBP by the viral protease 3CPro (128).  The host PCBP binds stem-loop 
IV during the IRES-driven translation and stem-loop I during viral RNA synthesis (128).  
The replication complex of PV is located on the surface of membranous structures 
proliferating in the cytosol.  In the course of PV RNA replication, there are various forms 
of viral RNAs synthesized in infected cells: the single stranded RNAs, the replication 
intermediate (RI) and the replicative form (RF) (128). A few minus-strand RNAs serve as  
templates for the synthesis of the positive single-stranded RNAs (128). The RF is a double-
stranded RNA (dsRNA) formed by full length copies of positive and the negative strands 
while the RI is an RNA on which multiple nascent positive single-stranded RNAs are 
synthesized (128).     
2.5.2 Poliovirus assembly and release 
The P1 domain, the viral polyprotein fragment that contains all structural proteins, 
is preferentially cleaved by viral protease 3CDPro to form three polypeptides VP1, VP3 and 
the immature VP0 (160). The three polypeptides VP1, VP3 and VP0 form protomers. In 
the course of viral assembly, five protomers aggregate to generate pentamers of which 
twelve spontaneously assemble to form a procapsid (36, 160). Procapsid particles are made 
up of 60 copies each of VP1, VP2 and VP0. It remains unknown whether the viral genome 
is inserted into the procapsid or enclosed during assembly of pentamers. The packaging of 
PV genome leads to the formation of a provirion, which contains the RNA. The immature 
polypeptide VP0 likely undergoes autoproteolytical cleavage to yield VP2 and VP4 capsids 
proteins, thus converting the provirion into an infectious particle. Poliovirus is the most 
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studied virus in the picornaviridae family, it can serve as a model to understand the biology 
of other existing related virus with high public health and economic impacts.  
2.6 Origin and functioning of poliovirus replication organelles   
2.6.1 Overview 
The replication complexes of poliovirus are intimately associated with 
membranous structures (also known as replication organelles (RO)) in the cytosol (101). 
These membranous structures were first detected by Kallman et al. in poliovirus-infected 
rhesus monkey kidney cells. The authors observed the appearance of dense materials they 
called cytoplasmic bodies, or U bodies, proliferating in great numbers in the cytosol of 
polio-infected cells (78). Membranous structures induced in poliovirus-infected cells 
appeared as vesicles or rosette-like structures and varied in size between 70-400 nm (101). 
Belov et al. have shown that these structures had complex spatial morphology and featured 
single membrane at the early stage of replication and double membranes in the late stage 
of replication (Figure 2.5) (14).  
All positive strand RNA viruses of eukaryotes share this reorganization of 
intracellular membranes upon viral infection. Viruses from the Flaviviridae (Dengue virus, 
Hepatitis C virus, and West Nile virus), Togaviridae (Semliki forest virus, Sindbis virus, 
and Rubella virus), Bromoviridae (Brome mosaic virus), and Coronaviridae (Severe acute 
respiratory syndrome coronavirus, Mouse hepatitis virus) families induce profound 
remodeling of intracellular organelles and proliferation of membranous structures that 
support the replication complexes (57). These groups of positive-stranded RNA viruses 
largely induce two types of membranous structures upon infection: invaginated vesicles 
(InV) or spherule type and the  double membranes vesicles (DMV) type (57). In the case 
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of picornaviruses, single membrane branching tubular structures filled with cytoplasmic 






Figure 2.5: Reconstructions showing the 3-D architecture of poliovirus membranous 
replication complexes at the early (3 h.p.i.), intermediate (4 h.p.i.), and late (7 h.p.i.) 
stages of development. (A, D, and G) Central slices in tomographic volumes. (B, E, and 
H) Central slices with segmented overlays. (C, F, and I) Segmented volumes, with blue 
indicating single-membrane structures and yellow and green indicating inner and outer 
membranes of double-membrane structures, respectively. Bar, 100 nm. Figure adapted 
from George A. Belov et al (14) 
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Although the functional role of these membranous structures in the viral life cycles is not 
well understood, it is hypothesized that they may serve multiple purposes in the 
development of infection. Thus, they may increase local concentration of viral and host 
proteins associated with the replication, serve as a structural support for the proper 
assembly of the replication complexes and hide the replication complexes from cytosolic 
sensors of viral infection such as PKR, RGI-l and MDA5 (101).  
2.6.2 Role of poliovirus proteins in the development of replication organelles 
The expression of non-structural proteins of picornaviruses can induce the 
remodeling of intracellular membranes similar to those observed during infection (148).  
The poliovirus proteins 2B, 2C and 3A have membrane-targeting domains. Thus, to 
understand their role in the rearrangement of intracellular membranes, several group 
expressed various poliovirus polyprotein fragments or individual proteins with the help of 
a recombinant vaccinia virus. The expression of poliovirus non-structural proteins 2C or 
2BC stimulated the modification and the proliferation of membranous structures similar to 
those found in infected cells (32). Interestingly, the introduction of mutations in the 
membrane-binding motif of either 2C or 2BC did not prevent the rearrangement and 
proliferation of membranous vesicles (32).  
The expression of poliovirus proteins 3A alone or in combination with 2BC 
generated membranes vesicles structurally similar to those observed in infected cells (145). 
In other families of positive strand RNA viruses, the remodeling of pre-existing membranes 
could also be driven by the expression of non-structural proteins with hydrophobic 
signaling. In the family Flaviviridae, the rearrangement of ER is induced by the expression 
of the viral protein NS4A in the case of DENV and WNV. In the case of HCV, it was 
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shown that the expression of the combination of structural proteins core-E1-E2-p7 or the 
non-structural proteins NS3-4A and NS4B were capable to induce the formation of DMV 
or “ membranous-web” (161). While the expression of the viral membrane-targeted 
proteins is capable of inducing membrane alterations, it is not clear if such membranous 
structures fairly represent membrane remodeling observed during infection or just share 
superficial morphological resemblance with the replication organelles.  
2.6.3 Origin of poliovirus membranous replication organelles 
The origin of the replication membranes vesicles is not well understood, although 
several proteins markers from various intracellular organelles (endoplasmic reticulum, 
lysosomes, cis- and trans-Golgi) have been found associated to these replication organelles 
in the cytosol of PV infected cells (141). This suggests that either these replication 
organelles may come from multiple sources, or that extensive mixing of the intracellular 
membrane materials is induced during PV infection. The mechanism of how cellular 
membranes are transformed into the replication organelles is not known. To date, the 
following intracellular pathways have been hypothesized to contribute to the development 
of these membranous structures: the secretory pathway, the autophagy pathway and the 
lipid synthesis and trafficking pathways. 
2.6.3.1 The secretory pathway  
The secretory pathway allows the transport of proteins and lipids between the ER 
where they are synthesized through Golgi complex to plasma membrane and other 
intracellular organelles. The COPII coated vesicles mediate the anteretrograde transport of 
proteins and lipids from the ER to the ER-Golgi intermediate compartment (ERGIC) (107). 
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COPI-coated vesicles mediate the retrograde transport between the ERGIC compartment 
and the ER and also within the Golgi complex (107).  
Maynell et al. have shown that the replication of poliovirus was severely inhibited 
when cells were treated with brefeldin A (BFA) (97). BFA, a fungal metabolite, blocks the 
transport of proteins between the ER and Golgi complex via the prevention of the COPI-
coated vesicle formation. The primary target of BFA is a family of guanine nucleotide 
exchange factors (GEFs) GBF1, BIG1 and BIG2 involved in the activation of Arf GTPases 
from GDP-bound inactive to the GTP-bound active form. Belov G et al. have shown that 
the depletion of GBF1 with siRNA significantly inhibited the replication of poliovirus 
whereas overexpression of GBF1 rescued the viral replication in BFA-treated cells (72). In 
another study, Belov et al. demonstrated that viral protein 3CD specifically promoted 
binding of BIG1/2 to the membranes, thus confirming the involvement of elements of the 
intracellular secretory pathway to poliovirus replication (10). Rust et al. have shown that 
Sec13, a component of COPII coat, co-localized with viral protein 2B in poliovirus-
infected cells (134). Gazina et al. have demonstrated differential sensitivity of three genera 
of picornaviruses to brefeldin A (BFA).  
The replication of echovirus 11 (EV11) was strongly inhibited while parechovirus 
1 was partially sensitive to the presence of BFA (56). The replication of 
encephalomyocarditis virus (EMCV), a cardiovirus, was not altered in the presence of BFA 
(56). Similarly, O'Donnell et al. demonstrated that the replication of the Foot and Mouth 
Disease virus (FMDV), an aphtovirus, was insensitive to the presence of BFA (111).  
Surprisingly, although BFA was able to block the replication of poliovirus and some other 
picornaviruses, Belov et al. showed that the expression of poliovirus proteins from a non-
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replicating RNA was able to generate membranous vesicles in the presence of BFA (72). 
Thus, while elements of the secretory pathway are important for poliovirus replication, 
they are not likely to be directly involved in the structural development of the replication 
organelles.     
2.6.3.2 The autophagy pathway  
The cellular autophagy pathway has also been proposed to be an important source 
of membranes supporting the replication of poliovirus (145).  Autophagy is an intracellular 
catabolic pathway targeting damaged organelles and proteins for recycling (9). This 
pathway is activated by cellular starvation, pharmacological agents such as rapamycin, 
tamoxifen or viral infections (87). Autophagy is also a key branch of the innate immune 
response, involved in targeting cytosolic pathogen such as viruses and bacteria for 
degradation (9). During autophagy, damaged organelles and protein aggregates are 
engulfed in a crescent shape membranes termed phagophores in the cytosol (9).  The 
extremity of these phagophores will eventually fuse to form enclosed double membranes 
vesicles termed autophagosomes (9). These autophagosomes will fuse with endosomes to 
form amphisomes or with lysosomes to generate autolysosomes. Following the formation 
of autolysomes, their contents will be degraded by lysosome enzymes (9).  
The appearance of DMV that resemble cellular autophagosomes in the cytoplasm 
of PV-infected cells prompted Schlegel et al. to hypothesize that some elements of the 
autophagy pathway were involved in the formation of the replication organelles (141). 
Jackson et al. have shown that LC3, a key regulator of autophagosome formation was 
recruited to the replication complex of poliovirus and co-localized with viral protein 3A 
(73). In the same study, they demonstrated that the stimulation of autophagy in polio-
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infected cells with pharmacological inducers such as tamoxifen or rapamycin, promoted 
viral replication, whereas knockdown of LC3 or atg12 proteins, inhibited the extracellular 
yield of poliovirus (73). With these results, Kirkegaard and Jackson hypothesized that the 
DMV or autophagosomes-like structures appearing in the cytoplasm of enteroviruses-
infected cells may participate in a non-lytic release of cytoplasmic viruses (83). In this 
regard, recent work by Bird et al. showed via quantitative time-lapse microscopy the 
release of cytoplasmic materials of PV-infected cells in the absence of cells lysis (19). The 
result further supports the idea that the autophagy pathway could be involved in a non-lytic 
release of PV infectious particles.  
Other members of the picornaviruses family have also been shown to use elements 
of this pathway to support their replications. The Coxsackie virus group B3 (CVB3), 
another enterovirus closely related to poliovirus, uses elements of the autophagy pathway 
to promote its replication.  Wong et al. have observed the proliferation of DMV in the 
cytoplasm of CVB3 infected cells and increased processing of LC3 proteins (162). The 
induction of the autophagy with rapamycin increased the replication while its inhibition 
with 3-methyladenine or siRNAs targeting key proteins required for autophagosomes 
formation severely reduced the replication of CVB3 (162). In that same study, while they 
observed a strong activation of autophagy during CVB3 infection, they also showed that 
the inhibition of autophagosome-lysosome fusion significantly improved the replication 
(162). The increased lipidation of LC3-I proteins to LC3-II, the association of elements of 
this pathway with viral proteins, the proliferation of DMV were observed in various 
picornaviruses-infected cells such as FMDV, EMCV and EV71 (70, 110).  
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Although, the appearance of double membrane vesicles had suggested a possible 
role of components of autophagy in the development of infection, other studies produced 
conflicting data on the role of this pathway in the replication of picornaviruses. Whereas 
Klein  and Jackson demonstrated that the activation of the autophagy with rapamycin 
efficiently improved the replication of the human rhinovirus type 2,  Zaruba et al showed 
that the induction of autophagy does not affect the production of the same virus (84, 148). 
More recently, Alirezaei et al. demonstrated that coxsackievirus exploited the LC3 protein 
in an autophagy dependent or independent manners to provoke a massive rearrangement 
of membranes for replication (109). These observations demonstrated that at least some 
elements of the autophagy pathway are involved in the picornavirus life cycle but whether 
they directly support the development and/or functioning of the replication organelles or 
primarily facilitate virion maturation and/or non-lytic virus release at the end of infection 
is still actively debated.  
2.6.3.3 The lipid metabolism pathways.  
Poliovirus infection profoundly alters cellular lipid metabolism pathways. 
Cornatzer et al. were the first to show the modification of phosphatidylcholine, 
phosphatidylethanolamine, sphingomyelin and phosphatidylinositol metabolism during the 
development of poliovirus infection (92). In that study, they demonstrated that the 
synthesis of various phospholipids species increased dramatically after 240 minutes 
following infection with poliovirus type 1 (92). Other studies by Penman in 1965 and by 
Dales and Amako in 1967 showed that infection with poliovirus or mengovirus enhanced 
the uptake of lipid precursors such as choline (35, 91). The imported choline was readily 
incorporated in the plasma membrane, endoplasmic reticulum, nuclear envelope and 
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mitochondria membranes and was also found in membranous fraction associated with the 
viral replicase activity (35, 91). 
Mosser et al. demonstrated that the incorporation of lipid precursors such as choline 
and glycerol in poliovirus-infected cells correlated with smooth-surfaced membrane 
proliferation associated with formation of the viral replication complexes (49). Vance et 
al. later demonstrated that poliovirus infection stimulated the rate of phosphatidylcholine 
biosynthesis in Hela cells (153). The study was followed by Choy et al, who showed that 
the surge of phosphatidylcholine synthesis in poliovirus-infected cells correlated with an 
increased concentration of CTP nucleotides, which in turn stimulated the activity of the 
phosphatidylcholine rate limiting enzymes  
CTP: phosphocholine cytidylyltransferase (CCT) (34). In the same direction, 
Guinea  and Carrasco have shown that the continuous synthesis of phospholipids was 
required for an efficient replication of poliovirus (61). The alteration of the lipid metabolic 
pathway and the corresponding proliferation of membranous structures in the cytoplasm 
seem to be shared by many picornaviruses. Thus, Schimmel and Traub observed an 
increased synthesis of phosphatidylcholine in mengovirus-infected cells. These 
observations led them to speculate that the observed upregulation of lipids could be 
associated to the proliferation of smooth cytoplasmic membranes needed for the replication 
(70). Recent studies have shown that membranes enriched with specific 
glycerophospholipid facilitate the non-lytic release of infectious poliovirus particles. In this 
regard, Chen et al have shown that following infection, mature poliovirus particles were 
packaged in phosphatidylserine-enriched vesicles then non-lytically released from infected 




Together with upregulation of synthesis of structural phospholipids such as 
phosphatidylcholine and phosphatidylserine, picornavirus infection modifies the 
distribution and synthesis of a signaling lipid phosphatidylinositol-4-phosphate (PI4P) and 
cholesterol. Hsu et al have shown that during poliovirus and CVB3 infection, host factor  
phosphatidylinositol-4-kinase IIIβ (PI4KIIIβ) is selectively recruited to the replication 
organelles resulting in high enrichment of these structures in PI4P (66). Co-
immunoprecipitation demonstrated that PI4KIIIβ associates with 3A, 3AB, and 3D in the 
replication complexes in CVB3-infected cells. Depletion of PI4KIIIβ with siRNA 
treatments or the inhibition of its activity with pharmacological agent PIK93 profoundly 
reduced replication (66). IInytska et al. found that PV and CVB3 hijacked the clathrin-
mediated endocytosis pathway to direct cholesterol from the plasma membrane and the 
extracellular medium to the replication organelles, where it regulates polyproteins 
processing and promotes viral RNA synthesis (71). The same group demonstrated that the 
depletion of intracellular or the plasma membrane free cholesterol inhibited the replication 
of PV, CVB3 as well as the development of the replication organelles (71).  
The alterations of the lipid metabolism coupled to the remodeling of intracellular 
membranes have been reported for a wide range of families of positive-strand RNA viruses. 
It was shown that following HCV infection, a member of the Flaviviridae family, the 
phosphatidylinositol-4-kinase IIIα (PI4KIIIα) enzyme was recruited to the replication 
complexes to synthesize the PI4P (15). Berger et al. also showed that the inhibition of 
PI4KIIIα with pharmacological agents or silencing with siRNA treatments severely 
decreased HCV replication and membranous web formation (15). HCV infection 
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upregulates the synthesis of phosphatidylcholine and phosphatidylethanolamine to 
stimulate membranes syntheses in infected cells  (39). It was shown that the fatty acid 
synthetase (FASN) and the Acetyl-CoA carboxylase 1 (ACACA) enzymes, two key 
regulators of fatty acid synthesis, were required for the replication DENV and WNV, the 
other members of the Flaviviridae family (65, 94). The activity and the protein level of 
FASN increased dramatically in HCV infected cells. The flock-house virus (FHV), a 
positive-stranded RNA virus of the Nodaviridae family is known to induce formation of 
invaginated vesicles or spherules serving as replication organelles  (80). It was shown the 
FHV modulated the glycerophospholipid metabolic pathway and the inhibition of 
phospholipid synthesis severely decreases its replication as well as that of the Tomato 
bushy stunt virus (TBSV), a plant positive-strand RNA virus (80, 143). 
Taken together, the accumulated data demonstrate that activation of phospholipid 
synthesis and retargeting of lipid trafficking pathways support structural development of 
the replication organelles of diverse positive RNA viruses.  
2.7 The phospholipid synthesis pathway 
2.7.1 Overview 
Cellular membranes are made of a combination of different lipids. 
Glycerophospholipids, sterols, and sphingolipids are the principal structural lipids of  
eukaryotic membranes (47). Among the glycerophospholipids, phosphatidylcholine (PC) 
and phosphatidylethanolamine (PE) constitute 50% and 25%, respectively, of the 
phospholipid mass in eukaryotic cells (66). The synthesis of glycerophospholipids, which 
happens in the ER and Golgi, requires the supply of long chain fatty acids and head groups 
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such as choline, ethanolamine or serine. Fatty acids are the main constituent of the 
hydrophobic domains of membranes.  
There are three major sources of fatty acids available for lipid synthesis: 
mobilization from lipid droplet storage depot, the de novo synthesis of fatty acids by FASN 
and import from the extracellular medium. For fatty acids to enter the metabolic or the 
catabolic pathways, the synthesis of fatty acyl-CoA is a prerequisite step, and this process 
is facilitated by acyl-CoA synthetases. This activation confers hydrophilic properties to the 
previously hydrophobic molecule. Composition of long chains fatty acids determines the 
physical properties of cellular membranes such as fluidity, permeability and flexibility. The 
head group of phospholipids such as choline must be provided as a vitamin, while serine 
and ethanolamine can be synthesized de novo, at least by some cell types, but are also 
actively imported from the extracellular medium. Upon their importation, they must be 
phosphorylated to enter the lipid metabolic pathway.  
2.7.2 Glycerophospholipid biosynthesis  
2.7.2.1 Acyl CoA synthetase enzymes 
The long chain acyl-CoA synthetases (ACSL), the very long chain fatty acid 
transport protein (FATP), and the acyl-CoA synthetases bubblegum (ACSBG) are enzymes 
responsible for the transport and activation of long chain fatty acids. The human genome 
possesses thirteen genes encoding these enzymes (123). The ACSL family has five 
isoforms, the FATP family has six isoforms and the ACSBG two isoforms each encoded 
by a separate gene (123). The acyl-CoA synthetase enzymes differ by their substrate 
specificities for FAs, sub-cellular locations, and tissue expression (65). ACSLs and FATPs 
are located on almost all intracellular organelles: the ER, mitochondria, peroxisomes, lipid 
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droplets and the plasma membrane (65). ACSBG is mainly localized in the cytoplasm, the 
mitochondria or microsomes of brain cells (123).  The long chain acyl-CoA synthetases 
control the transport of FAs across cellular membranes. The import of fatty acids across 
the plasma membranes proceeds via passive diffusion and can be facilitated by fatty acids 
transporter proteins located in the plasma membranes (21). Contrary to ACSL, FATP and 
ACSBG enzymes, FAs transporter proteins such as acyl-CoA binding proteins (ACBP), 
fatty acid binding proteins (FABP) and fatty acid translocase (FAT/CD36) do not possess 
acyl-CoA synthetase activities. However, they regulate the concentration of free fatty acids 
and free fatty acyl-CoAs in the cytoplasm.  
The import of fatty acids from extracellular milieu is a reversible process unless 
they are activated by ACSL, FATP and ACSBG enzymes or bound by cytosolic fatty acids 
transporter proteins (21). The activation of FAs by acyl-CoA synthetases is a two-step 
reaction requiring energy form ATP hydrolysis (65). 
 
                                                   FA + ATP→ acyl- AMP + PPi  
                                                   Acyl - AMP + CoA → Acyl - CoA + AMP  
 
Fatty acyl-CoAs are transported towards various metabolic sites such as ER for the 
synthesis of phospholipids, or mitochondria for β- oxidation. Overexpression studies and 
knock-down experiments of acyl-CoA synthetases have shown that some isoforms channel 






2.7.2.3 Phosphatidic acid biosynthesis 
The endoplasmic reticulum is the major site of glycerophospholipid biosynthesis. 
This process starts with the conversion of glycerol-3-phosphate (G3P) into phosphatidic 
acid (PA) by acyl transferase enzymes (79). Similarly to acyl-CoA synthetases, these 
enzymes differ by their substrate specificities, sub-cellular locations, and tissue expression 
(147). The glycerol-3-phosphate acyltransferase (GPAT) and the acylglycerolphosphate 
acyltransferase (AGPAT) enzymes are membranes-associated proteins with multiple 
isoforms, mainly located in the ER and the mitochondria. The GPAT protein has four 
isoforms (GAPT1-4) and AGPAT protein has close to ten isoforms (AGPAT1-10) (147). 
The glycerolphosphate acyltransferase (GPAT) catalyzes the synthesis of lysophosphatidic 
acid (LPA) by attaching a fatty-acyl to the sn-1 position of the G3P (147). Following the 
synthesis of LPA, the acylglycerolphosphate acyltransferase enzymes (AGPAT) will 
synthesize the phosphatidic acid (PA) by catalyzing the attachment of the second fatty acyl  









Figure 2.6: Scheme of the glycerophospholipid biosynthesis (Source: courtesy of Dr 
George Belov) 
 
2.7.2.4 Phosphatidylcholine biosynthesis 
Following the synthesis of phosphatidic acid, the phosphatidic acid phosphatase (PAP) 
enzyme catalyzes the dephosphorylation of PA to yield the diacylglycerol (DAG). The 
DAG serves as a substrate for the transfer of phosphocholine, phosphoethanolamine or the 
phosphoserine group, for the synthesis of phosphatidylcholine, phosphatidylethanolamine 
or phosphatidylserine respectively (147). The DAG molecule can also serve as a substrate 
for the synthesis of triacylglycerol (TAG) which is then stored in lipid droplets and this 
process is catalyzed by the diacylglycerolphosphate (DGAT) (147). Two pathways lead to 
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the biosynthesis of PC in cells, the CDP-choline pathway also termed the Kennedy 
pathway, and the phosphatidylethanolamine-methylation pathway, which is significant 
only in hepatocytes (80).  
Three enzymes are involved in the CDP-choline pathway: the choline kinase (CK), 
the phosphocholine cytidylyltransferase (CCT) which is the rate limiting factor in this 
pathway and finally the CDP-choline phosphotransferase enzymes (80). The CK initiates 
the first step in the phosphorylation of choline, and then the CCT catalyzes the transfer of 
a phosphate molecule to choline-phosphate to yield the CDP-choline (154). Finally, the 
CDP-choline phosphotransferase enzyme catalyzes the transfer of phosphocholine from 
the CDP-choline donor molecule to a diacylglycerol molecule to form the 
phosphatidylcholine (154). This enzyme is mainly located on the ER membranes and on 
the Golgi, MAM as well as nuclear membrane. 
CCT enzymes are expressed from two distinct genes: PCYT1a, which encodes CCT 
alpha (CCTα), and PCYT1b which encodes up to three isoforms CCT beta 1, 2 and 3 
(CCTβ1, CCTβ2, CCTβ3) (72). CCTα, the predominant form regulating PC syntheses is 
mostly found in the nucleus in its soluble state while CCTβ is a cytosolic resident protein 
(91, 92). CCTα, upon activation, relocates from the nucleus to intracellular organelles such 
as the ER where it drives the synthesis of PC. The CCTα gene has approximately 26 kb 
spanning 9 exons encoding specific domains.  Exon 2 encodes the nuclear localization 
signal as well as the translation start site, exons 4-7 encode the catalytic domain; the 
membrane-biding domain which has an alpha helical structure is encoded by exon 8 and 
finally, the C-terminal phosphorylation domain is encoded by exon 9 (154). The C-terminal 
phosphorylated domain and the membrane-binding domain regulate CCTα activity. The 
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inactive form of CCTα is extensively phosphorylated, however, it is dephosphorylated 
following activation and association with intracellular membranes (154).   
 
2.8 Goals of the study 
The upregulation of phospholipids syntheses and the proliferation of replication 
membranes is a shared hallmark of picornaviruses-infected cells. The goals of this project 
were:  
i. To understand the mechanism of the upregulation of phospholipid synthesis upon 
picornavirus infection. 
ii. To investigate the involvement of the ER stress response and the autophagy 
pathways in the modulation of lipid metabolism in infected cells. 
iii. To investigate the role of the activation of phosphatidylcholine synthesis in the 












Chapter 3: Materials and Methods 
3.1 Cells and viruses  
Hela cells and Human embryonic kidney (HEK) 293 cells were grown in Dulbecco 
Modified Eagle’s Medium (DMEM) containing 1X of penicillin/streptomycin, sodium 
pyruvate (1mM, Sigma), L-glutamine (2mM, Sigma) and supplemented with 10% heat-
inactivated fetal bovine serum (FBS). Poliovirus types 1 Mahoney (PV1), Coxsackievirus 
B3 (CBV3) and Encephalomyocarditis virus (EMCV) were propagated on Hela cells and 
the titer was determined by the standard plaque assay. Cells in monolayer were washed 
once with a serum-free DMEM, and then the virus was added with the desired multiplicity 
of infection (MOI) for 30mins in the room temperature. The infectious medium consisted 
of a serum-free DMEM supplemented with 50mM of Hepes at a PH 7.4. Following the 
adsorption, infected cells were incubated in a standard growth medium or serum-free 
medium according to the experimental design.  
To monitor poliovirus infection in the absence of PC synthesis, Hela cells were 
maintained in DMEM supplemented with 10% of heat-inactivated fetal bovine serum 
(FBS). The next day, the cultured medium was replaced by choline-free Earle’s balanced 
salt solution (EBSS) supplemented with non-essential amino acid mix (Sigma) and L-
glutamine (Sigma). After 48h of incubation in a choline-depleted medium, cells were 
washed once with EBBS solution then infected with a purified poliovirus kept in a 1X PBS 
and at the required MOI.  The purified poliovirus was isolated via the cesium chloride 
centrifugation assay. The infectious medium was made of EBSS solution with 50mM of 
Hepes pH 7.4. After 30mins of adsorption, infected cells were incubated according to the 
experimental design in the absence or in the presence of 200µM of choline in a standard 
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medium, in a serum-free EBSS or in EBSS supplemented with10 % of FBS. At the required 
time post infection, infected cells were processed for microscopic imaging    
3.2 Viral titration 
Hela cells infected grown in choline-free EBSS for 48h on a 12 wells plate were 
infected at 10PFU/cell then incubated in the presence or absence of choline. At 6hpi, the 
infectious supernatant was collected to assess extracellular infectious particles and infected 
cells were processed (freeze and thaw) to release intracellular infectious particles. For the 
plaque assay, Hela cells grown in a 6cm plate were infected with various dilutions of 
supernatant or intracellular infectious particles between 10-5 and 10-9.  The viral titer was 
evaluated by counting the number of plaques and the average from two wells were 
assessed. This formula was used to assess the titer:  
pfu/mL = Average of number of plaques/ Dilution factor * Volume of diluted virus added 
to the plate       
3.3 Plasmids. 
 Plasmids pTM-2A-3D, pTM-2B-3D, pTM2C-3D coding for the corresponding 
fragments of poliovirus cDNA under transcriptional control of T7 promotor and 
translational control of EMCV IRES were a gift from Dr. Natalya Teterina (NIH). PXpA-
RenR plasmid coding for polio replicon with Renilla luciferase gene substituting capsid 
region of polio genome was described elsewhere (10). Plasmid pTM-2Amut-3D containing 
mutation C109A in the 2A sequence was produced by point mutagenesis of the 2A 
sequence in pXpA-P2P3 (12) and recloning the PstI-SpeI fragment into pTM-2A-3D. For 
plasmid pXpA-SH-PV2A-HA coding for the full length polio cDNA containing 2A with 
HA tag the SpeI-SnaBI fragment containing 2A-HA was generated by two sequential 
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overlapping PCRs and recloned into pXpA-SH (12). Plasmid pTM-2A-HA for vaccinia-
based expression of 2A protein with HA tag PmlI-SalI fragment containing part of EMCV 
IRES and the whole coding sequence for 2A-HA was synthesized by Life technologies and 
was cloned into pTM-1 vector (gift from Dr. Natalya Teterina, NIH). All polio constructs 
were verified by sequencing. Plasmid pGFP-Acsl3-HA was generously provided by Dr. 
Joachim Füllekrug, University of Heidelberg, Germany. 
3.4 Fatty acids import assay 
To monitor the import of fatty acids, infected and mock-infected cells were 
incubated in the presence or absence of serum according to the experimental design. At a 
specific time, post infection, the incubation media was replaced by a pre-warm serum free 
media containing 0.4 μM of bodipy 500/520 C4-C9 (Molecular Probes) for 30mins at 37°C. 
Cells were fixed with 4% paraformaldehyde for 20 mins, washed with 1XPBS pH 7.4 and 
processed for microscopic imaging or fluorescence reading with TECAN infinite M1000 
plate reader.  
3.5 Fatty acid import competition assay.  
HeLa cells were grown on a 96 well tissue culture plate with transparent bottom 
overnight and the next day infected with poliovirus at 50 PFU/cell. After infection the cells 
were incubated either in standard or serum-free media as indicated. At 4 h p. i. the media 
was replaced with the same type of pre-warmed media supplemented with 0.4 µM of 
bodipy-FA label, 50 µM of the competitor fatty acid and 1µg/ml of cell-permeable DNA 
stain Hoechst 33342. After 30 min incubation the cells were washed with PBS and fixed 
with 4% formaldehyde in PBS and the Hoechst and bodipy-FA fluorescence were read in 
TECAN Infinite M1000 plate reader at excitation/emission 340/455 and 490/520 
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respectively. The bodipy-FA signal was normalized to Hoechst to account for variability 
in cell density and the data for each fatty acid are averaged form 12 wells. The data are 
expressed as percentage of the signal from control mock-infected cells incubated without 
any competitor fatty acid.  
3.6 Acyl-CoA synthetase activity measurement.  
HeLa cells grown on T75 flasks were harvested, washed 3 times with cold PBS 
and re-suspended   in STE buffer (8.5% sucrose, 10 mM Tris-HCl pH8.  0.5 mM EDTA) 
supplemented with protease inhibitors cocktail (Sigma-Aldrich).  Cells were lysed by 
twice freeze-thawing and the protein concentration of the lysates was determined by 
Bradford method.  The assay mix containing 500 nM Bodipy 500/510 C4-C9 substrate 
solubilized with α-cyclodextrin (10 mg/ml in 10mMTris-HCI pH 8.0), 40mM Tris-HCI 
pH 7.5, 10mM ATP, 10mM MgCl2, 0.2 mM CoA, and 0.2 mM dithiothreitol was 
assembled on ice, and the reaction was started by addition of an aliquot of cell 
suspension containing 60 µg of total protein. Duplicate reactions were incubated at 37C 
for 20 min and terminated by the addition of Dole’s solution (isopropanol: heptane: 2N 
H2SO4 40:10:1).  Newly synthesized fluorescent acyl-CoA was recovered in aqueous 
phase after 4 extractions with heptane and the fluorescence was measured by TECAN 
Infinite M1000 plate reader. 
3.7 Lipid extraction.   
Lipid extraction was performed according to Folch method (50). Cells grown on 
T75 flasks were harvested, resuspended in STE buffer (8.5% sucrose, 10 mM Tris-HCl 
pH8.  0.5 mM EDTA) and the protein concentration of cell suspension was determined by 
Bradford method.  An aliquot of cell suspension containing 1500 µg protein was adjusted 
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to 250 µl by STE in a glass tube and 3.75 ml of chloroform: methanol (2:1) with 5 mM 
HCl mix was added. The tube was vortexed for 30”, then 0.75 ml H2O was added, and the 
tube was vortexed again for 30” and centrifuged at 1500 rpm in a tabletop centrifuge for 5 
min. The top aqueous phase was discarded and lower organic phase was extracted 3 more 
times with Folch’s theoretical upper phase (chloroform: methanol: H2O 3:48:47). After 
extractions lipid-containing organic phase was dried under a stream of nitrogen gas. Lipids 
were re-suspended in 50 µl of chloroform before loading on TLC plates.  
3.8 Butanol extraction of Bodipy-FA 
To extract the fluorescent bodipy-FA from poliovirus- and mock-infected cells or 
cells treated with tunicamycin, thapsigargin and mock-treated, labelled cells were washed 
once then incubated with 1 mL of versen at 37 degree C. Following the incubation, 100uL 
of cells from each sample was collected to assess the concentration of proteins and the 
remaining 900ul was spun down at max speed for 5mins to collect cells pellet and discard 
the supernatant. Then, 500ul of butanol was added in each sample then incubated at room 
temperature. Following 10 min incubation, these samples were spun down and the 
supernatant was collected to measure the fluorescence. Then, 50ul of supernatant was 
distributed in a 96 wells plate which was then placed in a plate reader Infinite Tecan M1000 
machine to assess the fluorescence of bodipy-FA at excitation/emission of 490/520.  
3.9 Thin-layer chromatography (TLC).   
Thin layer chromatography glass silica plates (Analtech) were prewashed with 
chloroform: methanol (1:1) and air-dried.  Polar lipids were separated in chloroform: 
ethanol: water: triethylamine (30:35:7:35) and neutral lipids were separated in hexane: 
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ether: acetic acid (80:20:1). Phospholipids were stained with Phospray (Sigma Aldrich) 
and neutral lipids were detected with bromothymol blue spray (Sigma Aldrich).  
3.10 Propargylcholine labelling  
To monitor the synthesis of phosphatidylcholine, monolayers of Hela cells were 
infected with poliovirus at a required multiplicity of infection. At 5hpi, polio-infected cells 
were supplied with a medium containing 200uM of propargylcholine plus Hoechst in a 
mixed of L-glutamine (Sigma), amino acid (sigma) and the Earl’s balanced salt solution 
(EBSS). After 1 hour of incubation, the labelled cells were fixed with 4% of 
paraformaldehyde (PFA) for 25mins then washed three times with 1X PBS. The next day, 
labelled cells were stained with 5uM of Alexa Fluor 488 (lifetechnologies) via the click it 
“chemistry” protocol (lifetechnologies). 
3.11 Western Blot analysis 
Confluent monolayer cells were infected or mock infected with virus at a specific 
MOI or treated or mock treated with different drugs and incubated for a specific amount of 
time. According to the experimentation design, cells were washed with a cold PBS once 
then incubated with a mild cells lysis buffer (0.1M Tris-HCL pH 7.8; 0.5% Triton-X100) 
containing a protease inhibitor (Sigma-Aldrich) at a room temperature on a shaking 
incubator for 20mins. Cells lysates were collected and centrifuged at 4 C at a maximum 
speed for 5mins to collect the supernatant. The lysate was kept at -80 C for further 
processing for a SDS-PAGE western blot analysis. The western blot analysis was done on 
a 12-15% SDS-PAGE gels composed of H2O, ultra-pure 40% Protogel or Acrylamide: 
Bis-Acrylamide solution (Rational diagnostic), TEMED or N,N,N’,N’-tetramethyl-
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ethylenediamine (Rational diagnostic), 10% SDS (Cellgro), 1.5M Tris-HCL, pH8.8 and 
10% ammonium persulfate or APS (Rational diagnostic).   
Proteins were transferred on an immune-blot polyvinylidene difluoride (PVDF) 
membrane (Bio-Rad). Following the transfer, the membrane was sequentially incubated 
with the blocking buffer for then with the primary antibodies. Multiple membrane stripping 
was performed to analyze the expression of both viral and host proteins. The attachment of 
the primary antibodies was identified with either an anti-mouse or an anti-rabbit antibody 
attached to horseradish-peroxidase. The detection of proteins on the Immune-Blot 
membrane was done with ECL Select western blotting detection reagent (GE Healthcare).  
3.12 Digitonin permeabilization assay 
To examine membranes-associated proteins, Hela cells grown on a 12 wells plate 
were infected and incubated for 4hours in growth media. Following the incubation, infected 
and mock-infected cells were washed once with KHM buffer (110 mM K-acetate, 2 mM 
MgCl2, 20 mM HEPES-KOH, pH 7.4) then incubated for 5 mins in 50ug/mL of fresh 
digitonin solution in KHM buffer. After that cells were washed twice with KHM buffer 
then lysed with mild lysis buffer (0.1M Tris-HCl pH 7.8; 0.5% Triton-6100) supplemented 
with protease inhibitors cocktail (Sigma-Aldrich). The lysate cleared by low-speed 
centrifugation was used for western blot analysis.     
3.13 Vaccinia-T7 expression system 
Purified recombinant vaccinia virus expressing T7 RNA polymerase (VT7-3 [40]) 
was a gift from Dr. Natalya Teterina, NIH. The day before experiment HeLa cells were 
transfected with pTM- or pXpA-based plasmids coding for fragments of polio cDNA under 
transcriptional control of T7 RNA polymerase promoter and translational control of EMCV 
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or polio IRES respectively, with Mirus 2020 DNA transfection reagent according to 
manufacturer’s protocol. The next day cells grown on glass cover-slips were infected with 
vaccinia VT7-3 virus at a multiplicity of 10 PFU/cell in serum-free DMEM for 1 hour at 
37 C and then incubated for 4 more hours in standard growth media. After that the media 
was changed to pre-warmed serum free media supplemented with 5 mM of fluorescent 
fatty acid analog Bodipy 500/510 C4–C9 and the cells were incubated for 30 more minutes, 
then washed once with PBS and fixed with 4% formaldehyde in PBS and processed for 
microscopy analysis.   
3.14 Polio replicon replication assay.  
Polio replicon assay was performed as described in (11) with minor modifications. 
Briefly, HeLa cells grown on 96-well plates were transfected with polio replicon RNA with 
mRNA trans-it kit (Mirus) and incubated in TECAN Infinite M1000 plate reader at 37C 
for 16 hours in standard growth media supplemented with 30 M live cell Renilla substrate 
EnduRen (Promega). Measurement of Renilla luciferase activity was taken every hour post 
transfection, and the signal for each sample is averaged from at least 8 wells of the 96 well 
plates. 
3.15 Antibodies.   
Anti-Acsl3 mouse polyclonal antibodies were from Abnova; anti-Acsl5 mouse 
monoclonal antibodies were from Abcam; rabbit polyclonal anti-FATP3, anti-FATP4, 
anti-Acs bubblegum 2 were described in (75, 121, 122). Mouse monoclonal anti-polio 2B, 
2C and 3A antibodies were a gift from Prof. K. Bienz, University of Basel, Switzerland. 
Rabbit polyclonal anti-polio 3D antibodies were made by Chemicon using recombinant 
polio 3D protein as immunogen. Secondary anti-mouse and anti-rabbit highly cross-
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adsorbed goat antibodies conjugates with Alexa 350, Alexa 498 and Alexa 595 were from 
Molecular Probes.  
3.16 Reagents.   
Fluorescent fatty acid Bodipy 500/510 C4-C9 (bodipy-FA) was from Molecular 
probes. Unlabeled long chain fatty acids, Coenzyme A (CoA), ATP and neutral and 
phospholipid standards were from Sigma-Aldrich. Phosphatidylinositol 4 phosphate from 
porcine brain was from Avanti Polar Lipids. Fatty acid stock solutions were prepared in 
DMSO. Neutral and phospholipids were dissolved in chloroform. 
3.17 siRNAs.  
SiGenome siRNA pools and corresponding individual siRNA oligos targeting 
human long chain acyl-CoA synthetases were from Dharmacon. HeLa cells were plated at 
10000 cells/well in a 96 well plate and transfected with siRNA with Dharmafect 1 
transfection reagent (Dharmacon) according to manufacturer’s recommendations. After 72 
hours of incubation with siRNA the cells were used for polio replicon replication assay. 
Toxicity of siRNA treatment was assessed with Cell-Titer Glo luminescent assay 
(Promega).  
3.18 Microscopy.  
For immunofluorescent microscopy cells were fixed with 4% formaldehyde in PBS 
for 20 min. The cells labeled with Bodipy 500/510 C4-C9 were incubated with primary 
and secondary antibodies in 0.02% saponin in PBS with 5% FBS for 1 hour and were 
washed 3 times with PBS after each incubation. Secondary antibodies conjugated to Alexa 
350 were used for Bodipy 500/510 C4-C9-labeled cells since Bodipy 500/510 emits strong 
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fluorescence in both green and red spectra. Images were taken with Zeiss Axiovert 200M 
fluorescent microscope equipped with Axiocam Mrm monochrome digital camera.  
To observe the association of newly synthesized PC with membranes, polio and 
mock-infected cells labelled with propargylcholine were fixed with 4% PFA. 
Propargylcholine-labelled cells were incubated for 1 hour each with primary then 
secondary antibodies in 0.02% saponin in 1X PBS with 5% FBS. Cells were washed 3 
times each with 1X PBS between incubation. Because propargylcholine staining with 
Alexa fluor 488 had a green signal, the detection of viral antigen was done with Alexa fluor 
595 (red signal) and the detection nucleus done with Hoechst 33342 (Blue signal).  
3.19 Electron microscopy  
Hela cells were seeded in at a concentration of 125000cells/well in a 24 wells 
plate. The next day, the growth medium was changed from a choline-enriched DMEM 
plus FBS to choline-deprived Earle’s balanced salt solution (EBSS) plus L-glutamine 
and amino-acid. Following a 48 hours of starvation in a choline-depleted medium, cells 
were polio and mock-infected at a MOI of 50PFU/cell with a purified poliovirus for 30 
minutes then incubated in the presence or absence of choline. At 4 h.p.i, the incubation 







Chapter 4: The development of replication organelles is linked 
to a strong import of fatty acids and the increased activity of 
acyl-CoA synthetase enzymes in poliovirus-infected cells 
 
Parts of this chapter were published in Nchoutmboube JA, Viktorova EG, Scott AJ, Ford 
LA, Pei Z, et al. (2013) Increased Long Chain acyl-CoA Synthetase Activity and Fatty 
Acid Import Is Linked to Membrane Synthesis for Development of Picornavirus 
Replication Organelles. PLoS Pathog 9(6) 
 
4.1 Introduction 
Picornaviruses like all eukaryotic (+) RNA viruses, require association of the 
replication machinery with cytosolic membranes also called replication organelles (RO). It 
has been hypothesized these RO served multiple purposes in the course of the viral life 
cycle to facilitate the replication and propagation. They may serve as a structural scaffold 
for the formation of the replication complex, protect the replication complex from the 
cytosolic sensors of innate immune system and may help to increase the local concentration 
of viral and host proteins associated with the replication complexes. In case of 
picornaviruses, the development of these membranous structures has been attributed to the 
modification of the autophagy pathway, the cellular secretory pathway and the lipid 
metabolic pathway.  
The modification of these intracellular processes in poliovirus-infected cells has 
been described in the literature review (section 2.6.3). Not all picornaviruses rely on the 
secretory pathway for their replication, and similarly conflicting data support the 
importance of the autophagy pathway in the development of picornaviruses infections.  
Contrary to the secretory and the autophagy pathways, modification of the phospholipid 
synthesis has been consistently associated with the development of picornavirus infections. 
Synthesis of phosphatidylcholine, the most abundant phospholipid of cellular membranes, 
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is upregulated in many picornavirus-infected cells (27, 35, 70, 153). However, the 
mechanism of phosphatidylcholine and other phospholipid synthesis and its role during 
infection are not well understood.  
In this report, we demonstrated that poliovirus-infected cells manifest a dramatic 
fast increase in import of long chain fatty acids. In infected cells, imported fatty acids are 
rapidly incorporated into newly synthesized membranes, while in mock-infected cells they 
are destined for storage in lipid droplets. Mock-infected cells preferentially import long 
saturated fatty acids while in infected cells the spectrum shifts towards shorter and 
unsaturated fatty acids. Transport of fatty acids is intrinsically linked to their activation by 
acyl-CoA synthetases. We demonstrate a strong increase of acyl-CoA synthetase activity 
in infected cells and provide evidence that long chain acyl-CoA synthetase 3 (ACSL3) is 
the host protein involved in activation of fatty acids in infected cells.  
We identify poliovirus protein 2A as responsible for activation of fatty acid 
transport independent of its protease activity. Increased acyl-CoA synthetase activity in 
infected cells shifts the cellular lipid-synthesizing machinery towards production of new 
membranes and allows mobilization of fatty acids from all available sources – imported 
from external media, synthesized within the cell or released from lipid droplets.  Moreover, 
we show that import of long chain fatty acids is strongly activated upon infection of diverse 
picornaviruses in different cell types. Our data explain earlier observations of increased 
phospholipid synthesis in infected cells, provide a simple model for development of the 
membranous scaffold of replication complexes, and show how poliovirus can change 





Poliovirus infection increases the import of exogenous fatty acids and prevents 
their targeting to lipid droplets. The synthesis of phospholipids, the major constituents 
of cellular membranes, requires supply of precursor molecules including long chain fatty 
acids (154). To understand the metabolism of fatty acids upon infection, we used a 
fluorescent fatty acid analog bodipy 500/510 C4, 9 (bodipy-FA). Bodipy-FA is a synthetic 
fluorescent fatty acids which mimics a FA of 18 carbons backbone and is readily 
metabolized by living cells to synthesize various lipid species (98). Hela cells were 
poliovirus-infected at a multiplicity of infection (m.o.i) of 50 PFU/cell to ensure 
simultaneous development of infection, then labelled at 4 hours post infection (h.p.i) with 
bodipy-FA for 30mins in serum-free media.  
The result showed a strong import of bodipy-FA in poliovirus-infected cells (Figure 
4.1 A and B) compared to mock-infected cells (Figure 4.1 A and B). The imported bodipy-
FA accumulated in a characteristic perinuclear ring in poliovirus-infected cells (Figure 4.1 
C). In mock-infected cells, the label was distributed in multiples dots-like structures around 
the nucleus in the cytoplasm (Figure 4.1 E mock and D). These dots-like structures were 
later identified as lipid droplets as evidenced by co-localization of bodipy-FA with 
Adipocyte Differentiation-Related Protein (ADRP) a known marker of lipid droplets (159) 













Figure 4.1: Poliovirus induces a strong import of fatty acids.  A) low magnification view of 
mock and polio-infected cells; B) FACS analysis of  mock and polio-infected cells; C) Higher 
magnification of mock and polio-infected cells  showing bodipy-FA probe distributed in lipid 
droplets of mock and into membranes of infected cells; D) Confocal images of Hela cells 
transfected with pmCherry-ADRP and labeled with bodipy-FA; E) Confocal images of mock and 
polio-infected Hela cells labeled with bodipy-FA and Hoechst  33-342; F) confocal images of  
mock and polio-infected  Hela cells  labeled with bodipy-FA  then processed and  stained  for 


















To determine whether the imported fatty acids were used for the synthesis of 
membranes of the replication organelles, we stained cells for poliovirus membrane protein 
2B, a component of poliovirus replication complex (32). Staining of cells for 2B revealed 
an extensive co-localization of the fluorescent bodipy-FA and the replication organelles 
(Figure 4.1 F). This result demonstrated that import of long chain fatty acids is upregulated 
in polio-infected cells and that they were channeled towards the membranes of the 
replication organelles, whereas in mock-infected cells, the imported FA accumulated in 
lipid droplets.   
Imported fatty acids in infected cells are channeled towards the synthesis of 
phosphatidylcholine. To identify the metabolic destination of the imported fatty acids, 
HeLa cells were infected with poliovirus (mock-infected) at 50 PFU/cell and pulse-labeled 
for 30mins with the bodipy-FA at 4hpi in the presence or in the absence of serum. 
Following the incubation, labeled cells were processed for lipid extractions. The extracted 
lipids were resolved by thin layer chromatography (TLC) using two solvent systems 
optimized for the separation of either neutral or polar lipids.  The chromatogram was 
photographed in a fluorescence imager to identify newly synthesized lipids and then 
stained for total lipid content. We did not observe significant differences in the fluorescent 
label targeting cells incubated in the presence of serum, other than a weaker signal as it 
could be expected because of competition of serum lipids with bodipy-FA import.  
The signal from cells labeled in the absence of serum in the TLC optimize for the 
resolution of neutral lipids revealed targeting of Bodipy-FA to triglyceride synthesis in 
mock-infected cells (Figure 4.2 A, compare lanes 3 and 4), consistent with microscopic 
observations. Virtually no fluorescent compounds were resolved in neutral lipid system 
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from the material isolated from poliovirus-infected cells; the lipids extracted from infected 
cells remained as bright spots located at the loading position (Figure 4.2: A lanes 1 and 3). 
This result indicated that the synthesis of neutral lipids was inhibited in poliovirus-infected 
cells.  
Conversely, in the TLC system optimized for polar lipid resolution, poliovirus-
infected cells revealed a strong signal of phosphatidylcholine synthesis (Figure 4.2: B lanes 
1 & 3). Similar to neutral lipids, the total of polar lipids content extracted from polio and 
mock-infected cells incubated was not significantly different. Thus, PV infection does not 
only increase the level of FA import but modifies their metabolic channeling by down-
regulating the synthesis of neutral lipids and redirecting the newly imported FAs for the 


























Figure 4.2: In infected cells, synthesis of neutral lipids is shut down and imported fatty acids 
are directed to strongly stimulated synthesis of phosphatidylcholine. HeLa cells were infected 
(V) or mock-infected (M) with poliovirus at 50 PFU/cell and incubated in medium with or without 
serum as indicated. Bodipy-FA was added for 30 min at 4 h p. i.; after that total lipids were extracted 
and resolved by thin layer chromatography. A. Neutral lipids resolved in hexane: ether: acetic acid 
(80:20:1) system. Bodipy-FA-lipids represent fluorescent fatty acid-containing lipids synthesized 
during 30 min labeling period. Total lipids show all neutral lipids stained with bromothymol. B. 
Polar lipids resolved in chloroform: ethanol: water: triethylamine (30:35:7:35) system. Bodipy-FA-
lipids represent fluorescent fatty acid-containing lipids synthesized during 30 min labeling period. 
Total lipids show all phospholipids stained with Phostain. PC: 2-Oleoyl-1-palmitoyl-sn-glycero-3-
















Long chain acyl-CoA synthetase activity increases in poliovirus-infected cells 
and exhibits substrates preference for shorter fatty acids. The import and sequestration 
of long chain fatty acids in the cytosol  is intimately linked to the activity of long chain 
acyl-CoA synthetase enzymes (ACSL) (123). The ACSL enzymes catalyze the activation 
of hydrophobic fatty acids to yield hydrophilic acyl-CoA molecules, which are then 
channeled towards various cellular metabolic pathways including synthesis of membrane 
lipids (123). To monitor the activity of ACSL enzymes, lysates of Hela cells infected at a 
multiplicity of 50 PFU/cell and incubated at different times post infection in the absence 
of serum were collected. Bodipy-FA was added to the lysates, incubated for 20 mins, and 
the hydrophilic acyl-CoAs were separated from the hydrophobic input bodipy-FA.  Lysates 
of infected Hela cells displayed an increase in ACSL activity as early as 2 h.p.i and 
continued to steadily increase through 6 h.p.i (Figure 4.3: A).  
The cellular ACSL enzymes preferentially activate certain types of fatty acids 
however the substrate specificity is not strict (123). To identify the substrate preference of 
ACSL activated upon infection, we performed a fatty acids competition assay. Infected 
(mock-infected) Hela cells were incubated at 4 h.p.i for 30 mins with bodipy-FA in the 
presence of a 125x molar excess of a competitor FAs. In this assay, if the FA competitor 
was the preferred substrate, this would result in decrease of bodipy-FA import and thus in 
reduction of the fluorescence signal. The control poliovirus-infected cells displayed the 
strongest incorporation of bodipy-FA of more than 250% relative to mock-infected cells 
regardless of the presence or absence of serum. The unsaturated fatty acids added in mock-
infected cells incubated with serum did not affect the import of bodipy-FA (Figure 4.3: C). 
Conversely in the absence of serum, we observed a noticeable increase of bodipy-FA 
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import in mock-infected cells incubated with linolenic (C18:3) or linoleic (C18:2) fatty 
acids compared to control (Figure 4.3: E) and which likely reflects stimulation of 
triglyceride synthesis by non-saturated fatty acids, a well-known effect. In poliovirus-
infected cells incubated with oleic (18:1), linoleic (C18:2) and linolenic (C18:3) fatty acids 
there was no stimulation of bodipy-FA incorporation but rather a small reduction of 
bodipy-FA import in the absence or presence of serum (Figure 4.3: C and E).  
In mock-infected cells incubated with serum, saturated fatty acids did not influence 
the incorporation of the bodipy-FA (Figure 4.3: B). In mock-infected cells incubated in the 
absence of serum, the strongest competitor was the palmitic acid (C16:0) (37% of mock 
control) followed by myristic acid (C14:0) (22% of mock control) (Figure 4.3: D). In 
contrast, myristic acid (C14:0) was the best competitor in polio-infected cells reducing the 
import of FAs in poliovirus-infected cells from 270% to 150% in the presence of serum 
and from 250% to 130% in the absence of serum (Figure 4.3: B) followed by palmitic acid 
which reduced the import of bodipy-FA from 250% to 190% in the presence of serum and 
from 270% to 220% in the absence of serum (Figure 4.3: D).  This result showed that total 
ACSL activity is increased in poliovirus-infected cells and that its substrate specificity is 
modified showing that different enzymes are responsible for the bulk of ACSL activity in 















Figure 4.3: Modulation of long chain acyl-CoA synthetase activity in poliovirus-infected cells. 
A. Acyl-CoA synthetase activity is stimulated as early as 2 h p. i. and continues to increase during 
the time-course of infection. Acyl-CoA synthetase activity in vitro assay was performed with 
lysates of HeLa cells collected at indicated times post infection, the data are normalized to the 
activity of the lysate from mock-infected collected at 2 h p. i., p-values are shown. B. and C. Fatty 
import competition assay performed with the cells incubated in serum- supplemented medium 
during the whole experiment. HeLa cells were infected (or mock-infected) with poliovirus at 50 
PFU/cell; at 4 h.p.i. bodipy-FA was added for 30 min in the presence of 1256 molar excess of the 
indicated long chain fatty acids. No competitor fatty acid was added to control samples. The data 
are normalized to the signal from the mock-infected control sample; p-values are shown. D. and 
E. Fatty import competition assay performed with the cells incubated in serum-free medium during 
the whole experiment. HeLa cells were infected (or mock-infected) with poliovirus at 50 PFU/cell; 
at 4 h.p.i. bodipy-FA was added for 30 min in the presence of 1256molar excess of the indicated 
long chain fatty acids. No competitor fatty acid was added to control samples. The data are 
normalized to the signal from the mock-infected control sample; p-values indicating significant 












Spectrum of PC molecules synthesized in poliovirus-infected cells is different 
form that in non-infected cells. We observed a strong import of bodipy-FA, an increased 
ACSL activity, a change in its substrate specificity and an upregulation of PC synthesis in 
poliovirus-infected cells. We further investigated whether the change in the ACSL 
substrate specificity could result in the synthesis of different species of PC molecules. To 
this end, we combined two methods: first, the TLC (used above) to identify and 
characterize phospholipids through their pattern of migration and second, the matrix 
assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF-MS) 
which allows mass identification of molecules. The PC molecules were identified and 
characterized through their pattern of migration on TLC then the reflection positive mode 
MALDI-TOF-MS was used to scan the TLC lane (Figure 4.4: A).  
The mass to charge ratio (m/z) was used to secondarily identify the major PC 
molecules and acyl chain variants (Figure 4.4: B). Early in the infection, we observed an 
increased diversity of PC molecules with short acyl chain variants at low Rf 
chromatography zone of the TLC lane whereas at high Rf, there was a drop in the diversity 
of PC molecules containing C18 chains (Figure 4.4: C). The analysis of the individual PC 
classes demonstrated a fast shift in the composition of PC species following poliovirus 
infection. Thus at 2 h.p.i, we observed a significant increase of PCs species with C18/C18 
and C16/C18 acyl chains variant and conversely a sharp drop with C16/C16 and C14/C16 
compared to mock-infected cells. This trend continued later in the infection at 4 h.p.i where 
PC molecules with C16/C18 acyl chains significantly increased compared to mock-
infected cells (Figure 4.4: D). Changes in lipid abundance at 6 h.p.i do not follow the 
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general trends observed at 2 and 4 h.p.i likely due to the significant degree of cell lysis 
















Figure 4.4: Shift in phosphatidylcholine spectrum following infection demonstrated by TLC-
MALDI. A. Schematic representation of TLCMALDI, blue spots represent phospholipid migration 
on TLC plate, hash marks represent stepwise MALDI data capture. B. HeLa cells were infected 
with poliovirus at 50 PFU/cell and processed for the total lipid extraction at the indicated time 
points post infection. TLC-MALDI data shown at phosphatidylcholine (PC) migration (Rf) range, 
fatty acid chain lengths noted, intensity of signal at respective mass to charge ratios (m/z) (blue 
scale). C. PC diversity (unique m/z signatures) shifts in abundance from higher Rf to lower Rf 
during time course of infection. D. Percent change of PC subset/PC total ratio compared to mock. 

























Once activated, the increase of FA import in infected cells does not depend on 
active viral RNA replication or translation and is independent of new cellular genes 
expression. Poliovirus infection rapidly shuts down intracellular metabolisms such as the 
host gene transcription, nucleo-cytoplasmic trafficking and translation initiation (43). Here, 
we investigated whether the continuing expression of viral proteins and the viral RNA 
synthesis is required for increased import of bodipy-FA by infected cells. To this end, we 
monitored the import of bodipy-FA in the presence of guanidine-HCL (GUA), a known 
inhibitor of poliovirus replication, or cycloheximide (CHI), an inhibitor of eukaryotic 
translation (2, 104).  Cells were infected at the MOI of 50 PFU/cell and incubated for a 
period of 3.5h, then we replaced the medium with a fresh medium containing 2mM of GUA 
or 10µg of CHI. After 30 mins of incubation to allow inhibitors to enter cells, the medium 
was again replaced with the labelling medium also containing the respective inhibitors and 
bodipy-FA. After 30mins of incubation, cells were fixed and processed for microscopic 
imaging.   
Thus, the cells were exposed to GUA or CHI for a total of 1h (control cells were 
incubated without the inhibitors but underwent the same media changing procedures). The 
import of bodipy-FA in cells treated with an inhibitors of poliovirus replication GUA or 
translation inhibitor CHI was similar to that in control (Figure 4.5: D, E and F). We also 
monitored the import of bodipy-FA in poliovirus infected cells treated with actinomycin D 
(AMD), a known inhibitor of nuclear transcription, which was shown not to affect 
poliovirus replication (Figure 4.5: A) (69, 140). Prior to poliovirus infection, cells were 
pre-incubated for 30mins in the presence or absence (control) of AMD and the inhibitor 
was present for the whole time thereafter during infection and bodipy-FA labeling. The 
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activation of bodipy-FA import was not affected by the presence of AMD (Figure 4.5: B 
and C).  
These results show increase of FA import in infected cells does not depend on new 
expression of cellular genes and likely relies on activation of pre-existing cellular factors 







Figure 4.5: The fatty acid import does not depend on the active viral replication, translation 
and is independent of genes expression. A. Effect of the inhibitors on polio replicon replication. 
HeLa cells grown on a 96 well plate were transfected with a polio replicon RNA with the Renilla 
luciferase gene substituting capsid region. Luminescence was monitored in live cells incubated 
with Endu-Ren substrate added in the media. Actinomycin D (AMD, an inhibitor of nuclear 
transcription) was added to the cells for 30 min before the replicon transfection and was present in 
the incubation media thereafter at 5 µg/ml. Cycloheximide (CHI, an inhibitor of mRNA translation) 
and Guanidine-HCl (Gua a specific inhibitor of polio replication at this concentration) were added 
at the time of transfection at 10 µg/ml and at 2 mM respectively. Equivalent amount of DMSO 
(solvent for AMD) and water (solvent for CHI and Gua) were added to the control cells. B. and C. 
HeLa cells were pre-incubated for 30 min with 5 µg/ml AMD) (equivalent amount of the DMSO 
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solvent was added to the control cells) and infected with poliovirus at 50 PFU/cell. After 4 hours 
incubation in the standard media in the presence of AMD (DMSO in control) the cells were labeled 
for 30 min with 0.4 µM bodipy-FA in pre-warmed serum-free media also in the presence of the 
inhibitor (DMSO in control). After the incubation with the label, the cells were washed with PBS 
and fixed with 4% formaldehyde in PBS. Fluorescence (bodipy-FA) and phase contrast images are 
shown. D–F. HeLa cells were infected with poliovirus at 50 PFU/cell and incubated in standard 
growth media for 3.5 h; after that, the media was replaced with pre-warmed media containing: D. 
(control) equivalent amount of water (solvent for CHI and Gua) E. 10 µg/ml CHI. F. 2 mM GUA. 
The cells were incubated for 30 more min, and then the media was replaced with pre-warmed 
serum-free media containing the same inhibitors (water in control) and supplemented with 0.4 µM 
of bodipy-FA label. After 30 min incubation with the label, the cells were washed with PBS and 
















ACSL3 is required to support effective poliovirus replication.  To understand 
the role of acyl-CoA synthetase enzymes in the replication of poliovirus, we performed 
poliovirus replicon replication assay in Hela cells treated with pools of siRNAs targeting 
all thirteen human long chain acyl-CoA synthetase genes. Of all treatments, only siRNA 
targeting FATP5 gene was severely toxic to cells thereby eliminated for further 
consideration (Figure 4.6). We observed a strong decrease of poliovirus replication of 
about 80% following knockdown of ACSL3, FATP3 and the ACSBG2 genes expression 
without compromising the viability of the cells (Figure 4.6). However, treatment of cells 
with individual siRNAs from FATP3 targeting pool did not result in a significant reduction 
of FATP3 expression.  
Similarly, the effect of anti-ACSBG2 siRNAs was non-specific since the enzyme 
is not expressed in HeLa cells. Anti-ACSL3 siRNAs on the other hand demonstrated 
specific inhibition of ACSL3 expression (not shown), thus the siRNA knock-down 
experiments suggested an important role of ACSL3 enzyme in poliovirus replication. To 
further characterize the inhibitory effect of ACLS3, additional treatments of Hela cells with 
various pools of siRNAs targeting ACSL3 significantly reduced the replication of 







Figure 4.6: HeLa cells grown on 96 well plates were transfected with siGenome siRNA pools 
targeting all known human long and very long chain acyl-CoA synthetases, 16 wells for each 
siRNA pool. siControl scrambled siRNA (Dharmacon) served as a control. After 72 h incubation 
with siRNA polio replicon replication assay was performed. Total replication is calculated as area 
under curve using Prizm software and the data are displayed as percentage of control. Toxicity was 
measured after replicon replication assay. siRNAs exhibited the strongest effect on replication 
(Acsl3, Acs BG2 and FATP3) are outlined in blue boxes. The toxic FATP5 siRNA is outlined by 





Our previous results demonstrated that the infection-induced increase of long chain 
fatty acid import does not require new cellular gene expression, suggesting that it relies on 
post-translational activation of pre-existing ACSL enzymes. Here we wanted to monitor 
possible post-translational modifications and/or changes in membrane association of 
ACSLs upon poliovirus infection. The amount of fatty acid transport protein 4 (FATP4) 
and ACSL5 protein did not vary in the course of infection (Figure: 4.7: A), however at the 
same time we observed proteolytic cleavage of FATP3 and to a lesser extend ACSL3 
protein (Figure 4.7: A). In spite of some cleavage, the total amount of FATP3 and ACSL3 
did not vary significantly between control and poliovirus-infected cells. Activity of ACSL 
enzymes depend in many cases on their association with specific membranes (95). 
Poliovirus infection induces the reorganization of intra-cellular membranes and the 
redistribution of host proteins.  
To monitor a possible redeployment of these enzymes following poliovirus 
infection, we performed a digitonin permeabilization assay. Digitonin extracts cholesterol 
from membranes thus permeabilizing cholesterol-reach plasma membrane and leaving 
intracellular cholesterol-poor membranes relatively intact. Cytosolic proteins are eluted 
from digitonin-treated cells; thus this method allows assessment of changes in membrane 
association of proteins. The viral membrane-associated proteins 2C and 2BC were 
recovered and the soluble protein 3DPol was partially depleted as expected in digitonin-
treated cells, confirming the efficiency of permeabilization (Figure 4.7: A + digitonin). The 
association of ACSL3, FATP4 and ACLS5 with intracellular membranes remained 
unchanged in the course of infection since these proteins were recovered following the 
digitonin treatment (Figure 4.7: A + digitonin). On the other hand, we observed a depletion 
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of FATP3 at 4 and 6 h.p.i, suggesting that its association with intracellular membranes was 
unstable in the course of poliovirus infection (Figure 4.7: A + digitonin, arrowhead).  
To further characterize the specific role of ACSL3 on the replication of poliovirus, 
a rescue experiment was performed to thwart the inhibitory effect of anti-ACSL3 siRNA 
by expressing a resistant ACSL3. Hela cells were co-transfected with the anti-ACSL3 
siRNA and pCI-ACSL3r plasmid coding for an ACSL3 sequence with a mutated siRNA 
targeting site. The polio replicon assay performed following a DNA transfection revealed 







Figure 4.7: Cleavage and redistribution of long chain acyl-CoA synthetases in infected cells 
and requirement of functional Acsl3 for polio replication and FA import. A. HeLa cells 
infected at 50 PFU/cells were incubated for 2, 4, and 6 hours post infection and collected for 
Western blot after permeabilization with digitonin for 5 min at room temperature (lanes 5–8); 
control cells (lanes 1–4) underwent the same treatment but without the detergent. Proteins were 
detected by multiple western blots of the same membrane after stripping of previous antibodies. 
Actin is shown as loading control. Results from a representative experiment are shown. Arrows 
indicate cleavage products detected with anti-FATP3 and Acsl3 antibodies. Arrowhead points to 
the loss of FATP3 after digitonin treatment from infected cells. B. Acsl3 knock-down severely 
impairs polio replicon replication (top panel) while showing minimal cytotoxicity (lower panel). 
siRNA knock-down efficiency of Acsl3 protein is shown. C. Expression of a fusion protein GFP-
Acsl3-HA reduces poliovirus replication. HeLa cells were transfected overnight with either empty 
pUC plasmid, pEGFP-N1 plasmid or pGFP-Acsl3-HA plasmid. Cells were infected (V) with 
poliovirus at 50 PFU/cell or mock-infected (M) and collected for analysis at 4 h.p.i. Polio 2C band 
intensity is normalized to the EGFP expressing sample. Expression of GFP-Acsl3 protein is 
detected with either anti-Acsl3 antibodies (second panel) or anti-GFP antibodies (third panel) 
which also show expression of EGFP (forth panel). Actin is shown as loading control. D. Knock-
down of ACSL3 expression reduces activation of FA import upon expression of poliovirus proteins. 
HeLa cells were transfected with control or ACSL-3-targeting siRNA and 48 h later they were 
transfected with the plasmid pTM-2A-3D coding for the entire poliovirus non-structural 
polyprotein fragment P2P3. The next day expression of polio proteins was induced by infection of 
cells with vaccinia-T7 virus. Bodipy-FA label was added for 30 min at 4 h post vaccinia-T7 
infection. Statistical analysis of, 150 cells from each sample shows bodipy-FA signal normalized 
to poliovirus antigen 2B fluorescence, p value is shown. Western blot shows ACSL3 knock-down, 









Figure 4.8:  rescue of the inhibitory effect of anti-Acsl3 siRNA#2 by expression of a 
resistant Acsl3. For the siRNA rescue experiment cells were transfected with the most 
potent anti-Acsl3 siRNA #2 (or control siRNA) and in ∼48 hours they were transfected 
with pCI-Acsl3r plasmid coding for the Acsl3 sequence with mutated siRNA targeting site 
(control samples were transfected with an empty vector). The next day after DNA 









Since siRNA knockdown demonstrated an important role of ACSL3 in polio 
replication, we investigated if its overexpression may stimulate the infection. Hela cells 
were transfected with plasmids coding for GFP-ACSL3-HA, this enzyme was fully 
functional in acyl-CoA synthetase activity assay (125), GFP or the empty vector pUC and 
then infected with poliovirus the next day at 50PFU/cells. A western blotting analysis of 
viral proteins showed that overexpression of the recombinant GFP-ACSL3-HA retarded 
the expression of poliovirus proteins, thus working as a dominant negative against polio 
replication (Figure 4.7: C). The result shows that either lack or excess of ACSL3 is 
detrimental to the replication of poliovirus.  
To understand if ACSL3 is the enzyme responsible for activation of long chain fatty 
acid import upon infection, we expressed the viral P2P3 polyprotein fragment with the help 
of vaccinia virus expressing a T7 RNA polymerase, in cells transfected with control and 
the anti-ACSL3 siRNAs. At 4hpi, vaccinia-infected cells were incubated in the presence 
of bodipy-FA in serum free media for 30mins to monitor the import of FAs. The result 
revealed a strong activation of FA import in cells treated with siRNA-control and positive 
for the viral antigen while accumulation of bodipy-FA was significantly lower in cells with 
ACSL3 knockdown (Figure 4.7: D).  
These data showed specific limited proteolysis of ACSL3 and FATP3 in infected 
cells, accompanied by the loss of membrane association of FATP3, which likely 
contributes to modulation of bulk ACSL specificity in infected cells, and demonstrate that 
functional ACSL3 is required for polio replication and is directly involved in activation of 




Poliovirus protein 2A is required for the activation of fatty acid import 
independently of its protease activity. To identify viral proteins associated with the 
increased import of bodipy-FA in poliovirus- infected cells, we expressed various 
polyprotein fragments of poliovirus with the help of a recombinant vaccinia virus which 
provided the T7 RNA polymerase (15). This system, which had been used previously to 
study the role of poliovirus proteins in the development of membranous structures (32), 
ensured a fast expression of viral proteins independently of RNA replication. Cells were 
transfected with plasmids coding poliovirus polyprotein fragments under the 
transcriptional control of a T7 RNA polymerase promoter. The next day, they were infected 
with the recombinant vaccinia virus which expressed the T7 RNA polymerase. Cells were 
incubated with the fluorescent bodipy-FA for 30mins at 4 hours post vaccinia virus 
infection and processed for microscopic observation or FACS analyses.  
The P1 domain coding capsid proteins is dispensable for poliovirus replication 
thereby, only fragments of the P2P3 portion of the polyprotein were expressed (Figure 4.8: 
A). Cells expressing the polyprotein fragment 2A-3D displayed a strong import of fatty 
acids compared to cells expressing the polyprotein fragments 2B-3D or 2C-3D (Figure 4.8: 
B) which demonstrated the level of bodipy-FA import comparable to that in control cells 
transfected with an empty vector pUC (Figure 4.8: B). These results show that the presence 







Figure 4.9: Activation of fatty acid import requires polio protein 2A. A. Schematic 
representation of poliovirus genome and truncated constructs used for expression of polio proteins. 
B. Only expression of the full P2P3 region activates import of bodipy-FA label (Arrows). HeLa 
cells were transfected with plasmids coding for the indicated polyprotein fragments under control 
of T7 promoter (empty vector for the control sample) The next day the cells were infected with 
vaccinia-T7 virus and labeled with bodipy-FA for 30 min at 4 h.p.i. Poliovirus antigen 3A is 
detected as a marker of expression of viral polyprotein fragments 2A-3D (complete P2–P3), 2B-
3D and 2C-3D. C. Protease activity of 2A is dispensable for activation of fatty acid import (arrows). 
HeLa cells were transfected with plasmids coding for the indicated polyprotein fragments under 
control of T7 promoter (empty vector for the control sample) The next day the cells were infected 
with vaccinia-T7 virus and labeled with bodipy-FA for 30 min at 4 h p. i. Poliovirus antigen 2B is 
detected as a marker of expression of the wt and 2A-mut containing P2–P3 polyprotein. D. Parallel 
samples to those shown in C were collected and analyzed for 2A protease activity and expression 
of viral proteins. Processing of eIF-4G (black arrow) is detected only in the sample expressing 
functional 2A protease (top panel). Accumulation of viral proteins detected by viral antigen 3D is 
comparable in all samples showing that the lack of 2A protease activity is because of the mutation, 














2A is a protease responsible for the separation of the capsid protein precursor P1 
from the P2P3 polyprotein and is also involved in cleavage of a number of cellular 
substrates rendering host cell permissive for polio replication (28). To determine whether 
the protease activity of 2A was required for the stimulation of fatty acid import, we 
introduced a point mutation in 2A sequence substituting the catalytic amino acid C109 to 
A to inactivate the proteolytic function (39). The expression of the P2P3 fragment with the 
2A mutant strongly stimulated fatty acids import to the level similar to wt. P2P3 fragment 
(Figure 4.8: C). The western blotting analysis showed that eIF4G, a known target of wild 
type polio protein 2A in infected cells (146), was not cleaved in cells transfected with the 
mutant P2P3 2Amut-3D (Figure 4.8: D). To investigate if the expression of poliovirus 
proteins 2A alone could stimulate the import of fatty acids, a plasmid expressing the 2A 
protein with an HA tag and the substituted catalytic domain C109A was constructed. The 
level of fatty acid import in cells expressing 2A-HA C109A mutant was similar to that in 
control cells (not shown).  
These data show that expression of poliovirus protein 2A is required but not 
sufficient for activation of fatty acid import and that its protease activity is dispensable.  
Activation of fatty acids import is a universal attribute of picornavirus 
infection. To determine whether the activation of fatty acid import in poliovirus-infected 
cells was a phenomenon specific to HeLa cells, we used different cell lines: Vero (green 
African monkey kidney) cells, 293 HEK (human embryonic kidney) cells and SH-S5Y5 
(human neuroblastoma) cells. These cells were infected at a multiplicity of 50 PFU/cell 
and pulse-labeled with bodipy-FA for 30min at 4hpi in a serum free medium. The result 
showed an increase of bodipy-FA import upon infection in all cell lines tested and the 
82 
 
formation of lipid droplets in mock-infected cells (Figure 4.9: A-C). An example of 
infected Vero cells shows that expression of the viral proteins correlates with a strong 
activation of fatty acid import (figure 4.9: D). To determine whether the increase of fatty 
acid import can also be induced by other members of the Picornaviridae family, Hela cells 
were infected with Coxsackie virus B3 (CVB3) and the Encephalomyocarditis virus 
(EMCV). CVB3 is a close relative of poliovirus belonging to the same Enterovirus C 
species, while EMCV is a distantly related picornavirus from the Cardiovirus genus. 
Following the infection at 50PFU/cell and pulse-labeling with bodipy-FA for 30mins, we 
observed a strong increase of fatty acid import in infected cells (Figure 4.9: E-F).  
These results show that the activation of fatty acids import could be a universal 









Figure 4.10: Activation of long chain fatty acid import is a general phenomenon of 
picornavirus infection. A–C. 293HEK (human embryonic kidney), SH-S5Y5 (human 
neuroblastoma) or Vero (green African kidney) cells were infected with poliovirus at 50 PFU/cell 
and incubated for 4 hours before 30 min label with bodipy-FA. Fluorescent and phase contrast 
images of infected and mock-infected cells are shown. D. Higher magnification of Vero cells 
infected with poliovirus and labeled with bodipy-FA like in C, showing that bodipy-FA 
accumulation is activated only in cells actively expressing viral proteins (arrow). E, F. HeLa cells 
were infected with either Coxsackie B3 virus or encephalomyocarditis virus at 50 PFU/ cell and 
incubated for 4 hours before 30 min label with bodipy-FA. Fluorescent and phase contrast images 


















The remodeling of intracellular membranes is an indispensable step in the 
development of picornavirus infection, however the underlying mechanism(s) remain 
unknown. In this report we demonstrated that the up regulation of lipid synthesis in 
picornaviruses-infected cells is accompanied by a rapid increase of long chain fatty acid 
import catalyzed by the activation of acyl-CoA synthetase activity. In mock-infected cells 
the fluorescent long chain fatty acid analog bodipy-FA accumulated in lipid droplets 
whereas in polio-infected cells it was immediately channeled for the synthesis of PC and 
distributed to the replication organelles.  
Thus, in infected cells the newly imported FAs were utilized for the synthesis of 
membranous structures that support the viral replication. In the course of infection, the 
increased activity of the acyl-CoA synthetases resulted in the synthesis of species of PCs 
with distribution of long chain acyl chains different from that in non-infected cells. 
Changes in PC species could determine the distinctive biophysical properties of the 
replication organelles. Although the fatty acid competition assay showed a strong 
preference for the import of the myristic acid C14, the synthesis of PCs species 
preferentially accumulated the palmitic acid C16 and the stearic acid C18, likely reflecting 
the relative abundance of different fatty acid species available for lipid synthesis. This 
result demonstrated that the development of replication organelles with unique lipid 
composition in PV infected cells to the large part depends on synthesis of new membranes 
and not only on the remodeling of pre-existing organelles.  
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ACSL enzymes have distinct tissue expression patterns and subcellular locations. 
A western blot analysis monitoring the expression patterns and membranes association 
following polio infection revealed some differences among ACSL enzymes. Thus, the 
expression of FATP4 and ACSL5 did not change significantly overtime and the treatment 
with digitonin showed they were forming stable associations with intra-cellular structures. 
Both ACSL5 and FATP4 proteins are located on the ER and the mitochondrial membranes 
(94, 123) and it is possible these associations and their acyl-CoA synthetase activities are 
not inhibited in the course of polio infection. Contrary to ACSL5 and FATP4, FATP3 and 
ACLS3 were cleaved in the course of infection and FATP3 significantly lost its association 
with membranous structures in polio infected cells.  
The accumulation of cleaved products of FATP3 and ACSL3 did not translate into 
a significant loss of the full length proteins. This suggested that possibly, a small fraction 
of these proteins were affected, probably in a specific subcellular location. At this stage, 
we do not know if viral proteinases 2A and 3C or intra-cellular proteases are involved in 
the proteolysis of ACSL3 and FATP3. The cap-dependent translation of host proteins and 
the nuclear transcription of host genes are rapidly shut down upon polio infection (43) thus, 
it is likely that the activation of pre-existing acyl-CoA synthetases is responsible for 
activation of fatty acid import and PC synthesis in picornaviruses infected cells. This also 
explains insensitivity of this process to an inhibitor of nuclear transcription Actinomycin 
D.         
Thirteen acyl-CoA synthase enzymes are involved in the activation and the 
transport of long and very long chain fatty acids with overlapping substrate specificity (65). 
The siRNA screening of all 13 human acyl-CoA synthetases showed that knockdown of 
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ACSL3 was the most potent in reducing polio replicon replication without inducing cellular 
toxicity. Curiously, overexpression of the recombinant GFP-ACSL3-HA also reduced the 
replication of poliovirus suggesting that the level of ACSL3 activity should be strictly 
regulated during infection or, alternatively that the recombinant protein worked as a 
dominant negative mutant due to the presence of GFP and/or HA elements. Although 
ACSL3 has the most significant effect on the reduction of polio replication following 
siRNA treatments, other acyl-CoA synthetases also modulated the infection albeit to a 
lesser effect. 
It was reported that siRNA knock-down of ACSL3 decreased the expression of 
several lipogenic transcription factors such as the peroxisome proliferator activation 
receptor-γ (PPAR-γ), carbohydrate-responsive element-binding protein (ChREBP), sterol 
regulatory element-binding protein-1c (SREBP1-c) and liver X receptor-α (LXR-α) (21). 
Here in our experiment, knock-down of ACSL3 significantly decreased fatty acid import 
and could also presumably perturb the activity of key enzymes involved in the synthesis of 
PC and other lipids associated to polio replication. The down regulation of ACSL3 via 
siRNA treatments was shown to inhibit the incorporation of fatty acids to PC and block the 
secretion of Hepatitis C virus (HCV) in human hepatoma Huh7-derived cells (143). Thus 
in our experiment, it is possible that siRNA knock-down of ACSL3 expression redirect FA 
away from PC synthesis and thus interfering with the development of poliovirus 
membranous replication organelles. 
We also observed that activation of bodipy-FA import required poliovirus protein 
2A. Through unknown mechanism, 2A could stimulate acyl-CoA synthetase activity only 
in concert with other viral factor(s) from the P2P3 polyprotein fragment. Interestingly, 
88 
 
while 2A is mostly known for its proteolytic functions in the viral life cycle, the proteinase 
activity of 2A was dispensable for the activation of fatty acid import. Thus, activation of 
acyl-CoA synthetase activity represents a novel function for this protein. Currently, the 
identity of host and viral factors that are involved in 2A-driven activation of ACSL activity 
is the subject of investigation.  
The fatty acid import seems to be universally activated in picornaviruses infected 
cells. Our data showed the import of FA was upregulated in CVB3 and EMCV infected 
cells as well as in various cell lines such as Vero cells, 293 HEK cells infected with 
poliovirus. It is possible that diverse picornaviruses rely on different acyl-CoA synthetase 
enzymes for activation of fatty acid import similarly to other enzymes involved in lipid 
synthesis. For example, the synthesis of PI4P for different genera of picornaviruses can be 
driven by different phosphatidylinositol-4-kinases. It was shown that poliovirus relied on 
the Golgi-localized phosphatidylinositol-4-kinase IIIβ (PI4KIIIβ) whereas EMCV relied 
on ER-localized PI4KIIIα to promote the synthesis of PI4P on replication organelles (47, 
66).  
Our data suggest a new model of the structural development of picornavirus 
replication organelles through the upregulation of synthesis of structural phospholipids, 
especially PC. Here, upon picornavirus infection, the increased ACSL activity provides an 
excess of long chain acyl-CoAs that drives the upregulation of phosphatidylcholine 
synthesis. The distinct substrate specificity of ACSL activity in infected cells results in 
synthesis of a different pool of phosphatidylcholine molecules which likely underlies the 
unique three dimensional shape of the replication organelles which have no analogues in 
non-infected cells (13). The modulation of fatty acid metabolism in infected cells 
89 
 
represents an attractive target for development of future broad spectrum antiviral 
therapeutics. 
 














Figure 4.11: model of the structural development of picornavirus replication 
complexes based on activation of cellular acyl-CoA synthetase activity by viral 
proteins (2A is required, but is not sufficient in case of polio). 
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Chapter 5: Activation of fatty acid import in poliovirus-




Picornavirus infection results in massive remodeling of intracellular membrane 
architecture.  Cells infected with poliovirus and other related picornaviruses rapidly 
develop clusters of novel membranous structures (replication organelles) harboring the 
viral RNA replication machinery. The replication organelles ultimately occupy almost all 
the cytoplasmic volume by the end of the infection cycle (13, 17, 18, 90). It was shown 
that in picornavirus-infected cells, the synthesis of structural phospholipids such as 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) is highly activated and that 
the newly synthesized lipids are found in membranes associated with the RNA replication 
activity (3, 103). We recently identified that increase of PC synthesis in infected cells is 
associated with strong activation of import of long chain fatty acids (FAs) which constitute 
the hydrophobic part of the phospholipid molecules.  
This activation of FA import was attributed to post-translational up-regulation of 
activity of the cellular long chain acyl-CoA synthetases which thioesterify FA moieties to 
coenzyme A (CoA) generating fatty acyl-CoAs (106). Acyl-CoAs serve as substrates in 
downstream metabolic reactions, including phospholipid synthesis.  Thus picornavirus 
infection induces profound changes in the basic cellular lipid metabolism, however what 
regulatory mechanisms are engaged upon infection to activate the lipid synthesis and 
ultimately the development of the membranous replication organelles is not clear.  
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Poliovirus genome RNA codes for one large polyprotein which is processed by viral 
proteases into about a dozens of mature peptides. Expression of membrane-targeted 
poliovirus proteins such as 2B, 2C, 3A and intermediate cleavage products containing these 
sequences was shown to significantly alter morphology of the intracellular membranes (31, 
149) and to inhibit normal trafficking of membranes and proteins through the cellular 
secretory pathway (16, 33, 40, 42), likely resulting in the activation of protective cellular 
mechanisms including ER stress response. 
 Moreover, poliovirus infection stimulates autophagy which was shown to promote 
maturation of infectious viral particles (130). Both ER stress response and autophagy are 
intimately linked to membrane metabolism (142, 144) and thus it is possible that changes 
in the lipid synthesis observed in infected cells, including activation of long chain FA 
import, are the results of activation of these pathways upon infection. 
5.2 Results and discussions 
To understand the role of the autophagy pathway in the import of exogenous FAs, 
HeLa or 293HEK cells were seeded on 12 well plates and the next day incubated with 5µM 
of autophagy inducer STF-62247 (Calbiochem) (group 1); corresponding amount of the 
DMSO solvent (group 2); or left untreated (groups 3 and 4) overnight. The next day the 
cells left untreated were infected with 10 PFU/cell of poliovirus type 1 Mahoney (group 3) 
or mock-infected (group 4). At 6 hours post infection medium from 4 wells of each group 
was replaced with pre-warmed DMEM containing 0.4 µM of Bodipy 500/510 C4, C9 
(bodipy-FA) (Molecular Probes) and 1 μg/ml Hoechst 33342 (Sigma), a cell-permeable 
DNA stain. Bodipy-FA is an analog of a long chain FA with 18 carbon atom backbone, 
and this and similar fluorescent probes are extensively used in membrane metabolism 
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research (77, 133). After 30 mins of incubation, cells were fixed and processed for 
microscopy observations and for fluorescence analysis in a Tecan Infinite M1000 plate 
reader as described in (155).  
Bodipy-FA fluorescence which reflects the import of long chain FAs from the 
medium was normalized to the Hoechst fluorescence which is proportional to the number 
of cells in the well (Fig. 1A). Parallel samples of cells from all groups were processed for 
western blot analysis. To follow the autophagy process, we monitored the processing of 
LC3B protein, which is required for the initiation of formation of autophagosomes, and the 
degradation of the polyubiquitin-binding protein P62/SQSTM1 (76). The P62 protein 
directly binds to LC3 on autophagosomal membranes and is degraded upon subsequent 
fusion of autophagosomes and lysosomes, thus the degradation of P62/SQSTM1 reflects 
the autophagosome maturation or “autophagy flux”.  (87, 115). P62/SQSTM1 degradation 














Figure 5.1: Activation of autophagy is not responsible for stimulation of the long chain FA 
import in poliovirus-infected cells. A. Scheme of the long chain FA import assay. B. Western 
blotting analysis of the protein expression in HeLa and 293HEK cells upon poliovirus infection or 
autophagy induction (STF-62247). Control cells were either mock-infected or treated with DMSO 
(a solvent for STF-62247). Expression of the viral proteins 2B and 2C is shown as the evidence of 
infection. Actin is shown as a loading control. C. Microscopy images of HeLa cells showing import 
of bodipy-FA (as outlined in A, at ~20 hours of treatment with autophagy inducer STF-62247 or 6 
hours post infection). D. Quantitative analysis of long chain FA import at ~20 hours of treatment 
with autophagy inducer STF-62247 or 6 hours post infection. Bodipy-FA fluorescence is 
normalized to that of Hoechst 33342, and the result is expressed relative to the mock-infected cells. 
Statistically significant differences are indicated. Statistical analysis was performed with Graph 












In both cell types, we observed a strong accumulation of the processed LC3B-II 
form upon treatment with STF-62247, confirming the efficiency of autophagy induction 
with this compound (Fig. 1B). HeLa cells treated with STF-62247 also showed an 
increased level of p62 compared to control sample, likely reflecting up-regulation of its 
expression during prolonged treatment with the autophagy inducer. The level of the 
unprocessed LC3B-I form was significantly lower in control HeLa than in 293HEK cells, 
indicating higher steady state level of autophagy in HeLa (Fig 1B). Accordingly, induction 
of LC3B processing upon poliovirus infection was much more noticeable in 293HEK than 
in HeLa cells. At the same time, degradation of p62 was observed only in HeLa and not in 
293HEK cells infected with poliovirus (Fig1B).  
Thus, it seems that poliovirus can efficiently induce autophagy in 293HEK cells 
(processing of LC3B) but not a significant maturation of autophagosomes (degradation of 
p62). In HeLa cells, on the other hand, the increase in autophagy induction is moderate, 
compared to the already high level of LC3B processing in non-infected cells, while these 
cells are much more conductive to completion of the autophagy cycle upon infection as 
revealed by strong degradation of p62. Both cell types support high level of poliovirus 
replication, as evidenced by robust expression of poliovirus proteins 2BC and 2C (Fig. 1B). 
Maturation of autophagosomes in infected cells was proposed to stimulate production of 
mature virions (130), it would be interesting to see if poliovirus replication in HeLa and 
HEK 293 cells would yield significantly different ratio of mature vs. immature viral 
particles. The level of FA import by either HeLa or 293HEK cells treated with STF-62247, 
and control DMSO-treated and mock-infected cells was not statistically different, while 
poliovirus-infected cells showed strong stimulation of FA import (Fig. 1C and D), in 
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accordance with the previously reported data (106). Thus, poliovirus-induced activation 
and completion of the autophagy program is likely cell type specific, and does not account 
for the activation of long chain FA import upon infection.  
To characterize activation of ER stress response upon poliovirus infection and 
possible contribution of this pathway in stimulation of long chain FA import HeLa cells 
were either infected (mock-infected) with 10 PFU/cell of poliovirus type I Mahoney or 
treated with 1 µg/ml tunicamycin or 0.5 µM thapsigargin, two well-established ER-stress 
inducers (138).  The cells were grown in 6cm dishes to provide sufficient material for RNA 
isolation to monitor splicing of the XBP1 mRNA as an indicator of ER stress induction 
(see below). At 6 hours post infection or addition of the ER-stress inducing compounds 
parallel samples were processed for: 1) long chain FA import assay as described in the 
previous section and (155) with some modification.  The cell incubated with 0.4 µM of 
bodipy-FA in DMEM for 30 mins were collected in 1000 µl of PBS and 100 µL of this 
suspension was used to measure the protein concentration for normalization, while the cells 
from the remaining 900 µl were collected by centrifugation and resuspended in 500uL of 
butanol to extract the lipids with incorporated bodipy-FA. 
 The butanol extract was clarified by centrifugation and divided into 5 replicates 
for fluorescence measurement in a Tecan Infinite M1000 plate reader. 2) RNA extraction 
with RNAeasy columns and subsequent mRNA enrichment with oligotex mRNA mini kit 
(Qiagene) following by RT-PCR to detect splicing of XBP-1 mRNA, a hallmark of ER 
stress response activation (138). 3) Preparation of the cytoplasmic lysate to analyze 
expression of ER-stress related cellular proteins and viral proteins in western blot.  Splicing 
of XBP-1 mRNA is initiated by the ER-resident endonuclease IRE-1 which is activated in 
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response to overload of the ER protein folding and processing capacity (26).  XBP-1 
protein expressed from the spliced mRNA is a potent transcription activator controlling 
expression of multiple genes including ER-targeted chaperons. Expression of these genes 
helps to resolve the ER stress conditions and restore the secretory capacity of the cells (86).  
We observed a very modest increase of the spliced XBP-1 mRNA in poliovirus-
infected compared to mock-infected cells (Fig. 2A) suggesting that either the ER 
homeostasis is not significantly perturbed upon infection in spite of the extensive 
membrane remodeling and high expression of membrane-targeted viral proteins leading to 
the inhibition of cellular secretion, or that poliovirus can actively counteract the cellular 
signaling machinery.  
In contrast, the cells treated with either tunicamycin or thapsigargin demonstrated 
a very strong processing of XBP-1 mRNA, as expected (Fig. 2A). Accordingly, we 
observed high expression of the transcription factor C/EBP homologous protein (CHOP) 
in cells treated with thapsigargin and tunicamycin, but not in infected cells (Fig2B). 
Expression of CHOP is activated upon induction of the ER stress response (138). Strong 
activation of the ER stress by tunicamycin or thapsigargin did not result in noticeable 
increase of the long chain FA import, which was only observed in poliovirus-infected cells 

















Figure 5.2: ER stress response is not activated upon poliovirus infection and does not result 
in increase of FA import. A. RT-PCR analysis of the splicing of XBP-1 mRNA in HeLa cells. 
XBP1u indicates the PCR fragment amplified from the un-spliced mRNA, XBP-1S is the fragment 
amplified from the spliced mRNA. Primers used in the PCR reaction are shown. B. Western blot 
analysis of the protein expression in HeLa cells upon induction of the ER stress (tunicamycin and 
thapsigargin) or poliovirus infection. Expression of the viral proteins 2B and 2C is shown as the 
evidence of infection. Actin is shown as a loading control. C. Microscopy images of HeLa cells 
showing import of bodipy-FA (as outlined in Fig. 1A, at 6 hours post infection or induction of the 
ER stress). D. Quantitative analysis of long chain FA import at 6 hours post infection or induction 
of the ER stress. Bodipy-FA fluorescence is normalized to that of Hoechst 33342, and the results 












It was previously reported that infection of RD cells with enterovirus 71 (EV71), a 
picornavirus related to poliovirus, induces implementation of some elements of the ER 
stress response, however such responses were detected at relatively late time points (9 
hours post infection and later) and were much less pronounced than those observed in 
control cells treated with pharmacological ER stress inducers (45). Interestingly, poliovirus 
replication was shown to be insensitive to treatment of COS-1 cells with 5 µg/ml of 
tunicamycin, sufficient to inhibit ER-specific N-glycosylation of proteins, and likely to 
induce strong ER stress response, although activation of the ER stress was not tested 
directly in this study (40).  
These data and our observations show that poliovirus and related picornaviruses 
neither significantly induce, nor are sensitive to the induction of the cellular ER stress, 
suggesting that their replication does not depend on the normal ER metabolism. Overall, 
our results demonstrate that activation of the long chain FA import and, consequently, 
activation of the structural phospholipid synthesis in picornavirus-infected cells is an 
infection-specific process that does not depend on cellular stress pathways such as 
autophagy and the ER stress response, and thus may represent an attractive target for anti-





Chapter 6: Role of phosphatidylcholine synthesis in the 
development of replication organelles and poliovirus life cycle 
 
Parts of this chapter were published in Jiantao Zhang, Zhenlu Zhang, Vineela 
Chukkapalli, Jules A. Nchoutmboube, Jianhui Li, Glenn Randall, George A. Belov, and 
Xiaofeng Wang (2016). Positive-strand RNA viruses stimulate host phosphatidylcholine 
synthesis at viral replication sites PNAS 2016 113: E1064-E1073. 
 
6.1 Introduction 
The origin of membranous structures supporting positive strand RNA viruses 
replication has been attributed to both the synthesis of new membranes and the complex 
rearrangement of preexisting intra-cellular organelles (57, 60). In our previous work, we 
have demonstrated that activation of PC synthesis upon infection relies on activation of 
acyl-CoA synthetase activity and that infected cells synthesize different spectrum of PC 
molecules than non-infected one. The upregulated phosphatidylcholine synthesis in 
infected cells likely supports the rapid structural expansion of the replication organelles, 
however, it is possible that certain enzymatic reactions of the replication cycle require 
specific phospholipid environment.  
For example,  phospholipids have been shown to influence the replicase protein 
activities of  positive RNA viruses from as diverse families as alphaviruses and nodaviruses 
(96, 158). Most recently, it was shown that an increased level of phospholipids such as 
phosphatidylethanolamine (PE) or phosphatidylserine (PS) enhanced the replication of 
tomato bushy stunt virus (TBSV) in PE-enriched vesicles or promoted the non-lytic release 
of infectious poliovirus particles packaged in PS-enriched vesicles (24, 89).  
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Here, we investigated the role of PC synthesis in the development of replication organelles 
and the effect of inhibition of PC synthesis on propagation of poliovirus.  
6.2 Results 
Phosphatidylcholine synthesis is required for the structural development of 
the replication organelles. Phosphatidylcholine is the most abundant lipid in cellular 
membranes and its synthesis is highly upregulated in poliovirus infected cells (106, 154). 
To understand the requirement of PC synthesis for the development of replication 
organelles, we first monitored the distribution of newly synthesized PC in polio-infected 
cells. Hela cells were infected with poliovirus (mock infected) at a MOI of 10 PFU/cell. 
The cells were incubated at 4 h.p.i with a 200uM of propargylcholine for 1h of incubation. 
Propargylcholine is a choline analogue that is readily utilized by cells in PC synthesis and 
propargylcholine-containing molecules can be detected by click-chemistry (74).  
The next day, the cells were processed for click chemistry detection of 
phosphatidylpropargylcholine with Alexa fluor 488 azide and immunostaining for a 
poliovirus antigen 2B as a marker of the replication complexes. The result showed an 
increased upregulation of PC synthesis in the cytoplasm of polio-infected cells compared 
to mock-infected and that the newly synthesized PC co-localized with the replication 
complexes as evidenced by 2B staining (Figure: 6.1). This result confirms previous 
observations made by us and the others that PC synthesized during infection is immediately 



















Figure 6.1: The newly synthesized PC co-localized with PV-2B in the replication complexes. 
Monolayers of Hela cells were infected at MOI of 10pfu/cells with poliovirus. Then at 4 hours post-
infection, the incubation medium was replaced by a labeling medium containing 200uM of 
propargyl-choline for 1 hour of incubation. PC was detected via click it chemistry protocol with 
Alexa 488 and the viral protein 2B was stained with Alexa fluor 594 and the nucleus stained with 
Hoechst-33342.  The co-localization panel shows the colocalized red and green pixels of 2B and 




















To investigate whether the structural development of replication organelles 
required PC synthesis, we monitored their formation and distribution upon incubation of 
infected cells in choline-deficient conditions. Human cells cannot synthesize choline and 
it needs to be supplied, as a vitamin in the medium, in its absence, no de novo synthesis of 
phosphatidylcholine is possible. Hela cells were incubated in a choline-free medium for 
48h prior to infection to let them exhaust their internal choline depot. After that, they were 
infected with poliovirus (mock-infected) at a MOI of 50 PFU/cells and then either further 
incubated in choline-deficient medium or in the medium supplemented with 25uM of 
choline.  
Control infection was performed in cells incubated all the time in standard growth 
medium supplemented with 10% fetal bovine serum. At 4h post-infection, cells were fixed 
and processed for transmission electron microscopy (EM) imaging. As expected, we 
observed strong proliferation of membranous replication organelles in control cells 
incubated in the presence of FBS; however, we observed almost no such proliferation was 
evident in cells incubated in choline-deprived medium. Virus-induced membrane 
alterations in such cells were represented by sparsely distributed enlarged cisternae- or 
vesicular-shaped structures likely representing dilated ER tubules. This phenotype could 
be largely rescued in choline-containing medium, although the replication structures in this 
case were still less tightly packed and had more elongated shape than those formed in 
control cells that did not undergo incubation in choline-deprived medium at any stage of 




Interestingly, although the inhibition of PC synthesis via choline starvation blocked 
the development of membranous structures, the western blot analysis showed that the 
expression pattern of viral proteins 2C in choline-depleted or choline-supplemented 
infected-cells was similar (Figure 6.2B). This result demonstrates that PC synthesis was 
required for the structural development of replication organelles in polio-infected cells but 
at the same time, PC synthesis is dispensable for the virus replication, at least in cell culture 
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Figure 6.2: PC synthesis is required for the structural development of membranes structures 
supporting the replication complexes.  Hela cells grown for 48h in a choline-depleted medium 
were polio-infected at a MOI of 50pfu/cell then followed by incubation in choline-enriched or –
depleted medium, or in the presence of 10% of FBS. At 4 h post infection, A) infected cells were 
either processed with a fixing solution for an electron microscopic imaging. Original image on the 
left with inset (Scale bar 2 microns) then inset magnified (Scale bar 500 nm) or B) cell lysates were 







Inhibition of phospholipid synthesis is dispensable for viral replication but is 
essential for protection against innate anti-viral mechanisms. The apparent uncoupling 
of the efficient poliovirus replication from the massive development of membranous 
replication organelles observed in choline-deprived cells prompted us to further investigate 
the role of membrane remodeling in poliovirus life cycle. First, we monitored if inhibition 
of PC synthesis would affect the non-lytic release of virus particles, a phenomenon that 
may depend on specific phospholipid composition of membranes (29). HeLa cells were 
pre-incubated for 48 h in choline-free medium to exhaust the cellular choline depot and 
infected with poliovirus at MOIs of 10, 1 and 0.1 PFU/cell. After infection, the cells were 
either incubated in choline-free medium or in medium supplemented with 25uM of choline. 
At 6 h.p.i, the supernatant was collected to assess the amount of released extracellular 
infectious particles and simultaneously infected cells were collected to measure the 
intracellular virus accumulation.  
The amount of extracellular particles recovered at 6 h.p.i. (i.e. representing the 
single round of infection) in all cases was ~3 logs lower than the amount of virus still 
associated with the cells. Moreover, the amount of intracellular and extracellular infectious 
particles did not vary significantly upon incubation of cells in choline-free or choline-
supplemented medium at any MOI (Figure 6.3 A, B and C).  
Thus, the non-lytic release of poliovirus is an inefficient process compared to the 
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Figure 6.3: The upregulation of PC synthesis is dispensable for the development of poliovirus 
infection at high MOI. Hela cells grown for 48h in a choline-depleted medium were polio-infected 
at MOI of A) 0.1 PFU/cell, B) 1PFU/cell and C) 10 PFU/cell then followed by incubation in the 
presence or absence of 25uM of choline. At 6 hours post infection, infected cells were processed 
via a plaque assay to quantitate the concentration of intracellular (freezing/thawing of infected cells 



















Next, we assessed the accessibility of the viral replication complexes in conditions 
of active and inhibited PC synthesis by immunostaining of a viral protein 2B, a marker of 
the replication complexes, in mild permeabilization conditions. Hela cells were pre-
incubated and cultured in the absence of choline for 48h then infected with poliovirus 
(mock infected) at an MOI of 10 PFU/cell and incubated for 4h in either choline-free or 
choline-supplemented media. At 4hpi the cells were fixed and processed for an 
immunofluorescence assay preceded by a mild treatment with 0.02% of saponin. Saponin 
selectively interacts with and removes cholesterol from membranes thus creating pores; 
saponin treatment largely preserves overall membrane architecture as opposed to strong 
detergents used for cell permeabilization like Triton-X100 that dissolve membranes. 
 In infected cells incubated in the presence of choline, the replication complexes 
formed a typical continuous perinuclear ring-like structure, this structure was efficiently 
stained only on the periphery, showing that the inner area is inaccessible to antibodies 
(Figure: 6.4). Contrary to the choline-supplemented medium, replication complexes 
formed in choline-free conditions appeared as evenly stained punctate scattered around the 
cytoplasm, demonstrating that they are readily accessible to antibodies (Figure: 6.4).  
This result demonstrated that the inhibition of PC synthesis prevents formation of 
tightly packed membranous structures of replication organelles and leaving the viral 
replication complexes more accessible by cytoplasmic proteins, including cellular sensors 





Figure 6.4: The upregulation of PC synthesis is required for the protection of the replication 
complexes from cytosolic factors. Hela cells grown for 48h in a choline-depleted medium were 
polio-infected at a MOI of 50PFU/cell then incubated in the presence of absence of 25uM of 
choline. At 4h post infection, infected cells were treated with 0.02% of saponin for 5mins then 
processed for an immunoassay staining with monoclonal antibodies targeting the membrane viral 




Infection in a natural host inevitably involves multiple rounds of infection 
ultimately resulting in activation of immune response. Our results suggest that activation 
of PC synthesis in infected cells while dispensable for a single round of replication is 
important for forming proper spatial structure of the replication membranes, limiting access 
to the sites of the RNA replication. Thus, its inhibition should likely allow the cells to 
detect the infection earlier and initiate the anti-viral signaling leading to activation of 
immune response. To investigate if PC synthesis and by extension the development of 
membranous replication organelles are important for suppressing cellular response to 
infection we infected cells previously incubated for 48 h in choline-free medium at low 
MOI of 0.1, 0.01and 0.001 PFU/cell followed by an overnight incubation in either choline-
free or choline-supplemented media. Since poliovirus replication time in HeLa cells is ~6 
h, multiple rounds of infection develop under these conditions. After that total virus yield 
was assessed.  
It should be noted that no toxicity was observed in mock-infected cells incubated 
in choline-free medium for the whole duration of the experiment. The concentration of 
infectious particles recovered after infection at the MOI of 0.1 PFU/cell was similar for 
either choline-free or choline-supplemented medium. At the MOI of 0.01 PFU/cell virus 
yield from cells incubated in choline-depleted medium was slightly lower, but not 
significantly, compared to that from the choline-enriched medium. At the lowest MOI of 
0.001PFU/cell the virus yield in choline-free medium was more than 2 logs lower than that 
in choline-supplemented medium (Figure 6.5).   
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Thus, inhibition of PC synthesis significantly reduced virus yield in conditions of multiple 
rounds of infection, likely because the replication complexes were not protected from the 




































































Figure 6.5: The development of poliovirus infection is sensitive to the inhibition of PC 
synthesis at low MOI. Hela cells grown for 48h in a choline-depleted medium were polio-infected 
at MOI of 0.001, 0.001 and 0.1 PFU/cell then followed by an overnight incubation in the presence 
or absence of 25uM of choline.  The next day, the concentration of the total infectious particles in 




6.3 Discussions  
In this project, we investigated the role of PC synthesis in the membrane 
remodeling in infected cells and the replication of poliovirus. The inhibition of PC 
synthesis via the choline starvation blocked the formation of membranous structures in the 
cytoplasm of poliovirus-infected cells. At the same time, the expression of viral proteins 
was similar in cells incubated in choline-depleted and choline–supplemented media. In line 
with this observation, active PC synthesis was dispensable for production of infectious 
viral particles in one round of infection at the broad range of MOIs. 
 However, since PC synthesis was required for the development of membranous 
structures, its inhibition resulted in increased accessibility of the viral replication 
complexes to cytosolic proteins. Accordingly, under conditions of multiple rounds of 
infections cells incubated in the absence of choline produced significantly less infectious 
virus than those in choline-supplemented medium, likely due to earlier detection of the 





Chapter 7: General Conclusion 
Positive RNA viruses constitute an important group of animal, and plant pathogens 
capable of inflicting serious economic damages and human and animal diseases. Although 
treatments options are available to prevent or cure infections from a few of these pathogens, 
the vast majority lacks vaccines or antivirals therapeutic. The limitation to the development 
of vaccines or inhibitors targeting specific viral proteins is linked to the incomplete 
understanding of the host-pathogen interactions and rapid development of drug resistance. 
Although positive RNA viruses are different in their size, genome organization or 
respective hosts, they share one common feature that is the remodeling and induction of 
membranous structures in infected cells.  
 These membranous structures, which are specialized sites of the viral RNA 
replication, derive from various intracellular organelles and have different shapes and 
structures depending on the specific virus (57, 141). The mechanism of development of 
these membranous structures has been attributed to the modification of intracellular 
processes associated with membranes metabolism such as secretory and the autophagy 
pathways. However, these pathways are differentially required for the replication of these 
viruses and do not fully explain the development of these replication membranes.  
The aim of this dissertation was to investigate the mechanism and role of activation 
of phospholipid synthesis in the development of membranous replication organelles of 
picornaviruses. In the chapter 4, we have shown that picornaviruses, upon infection, 
stimulate a strong import of exogenous fatty acids in infected cells. The newly imported 
fatty acids targeted lipid droplets in mock-infected cells while in infected cells they were 
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used for the upregulation of PC synthesis and served as a substrate for the synthesis of 
replication organelles supporting the replication complexes.  
The most important aspect of this result was the identification of ACSL3 enzyme 
as a novel host factor required for the replication of poliovirus and the import of exogenous 
fatty acids in polio-infected cells.  The ACSL3 enzyme belongs to the group of long and 
very long chain acyl-CoA synthetases (123). It was interesting to see that overexpression 
of the recombinant GFP-ACSL3-HA delayed the expression of viral proteins acting like 
an antagonist to replication. This result suggested that a functional ACSL3 with the normal 
structural configuration was required for the replication of poliovirus. Since ACSL3 was 
required for the upregulation of lipid synthesis and the replication of poliovirus, it may 
represent a potential target for anti-viral therapeutics. 
Another remarkable result of this section was the discovery of a novel function of 
the poliovirus proteinase 2A, which was required but not sufficient for the activation of 
fatty acid import. The mechanism of action of 2A in the import of fatty acids is not yet 
understood, but it was independent of its protease activity. The activation of fatty acid 
import is shared by diverse picornaviruses. It will be interesting as a future goal, to 
investigate the specific fatty acids composition of membranes structures supporting the 
replication complexes of different picornaviruses, how they affect the physical properties 
of the replication organelles such as shape, size, permeability and fluidity as well as the 




In chapter 5 of this project, we showed via pharmacological treatments, that the ER 
stress response and the autophagy pathway, two intracellular processes associated with 
membranes metabolism, were not responsible for the activation of fatty acid import of in 
polio-infected cells. The processing of X-box protein 1 (XBP1) gene, a transcription factor 
associated with the ER stress response and the expression of its downstream target CHOP 
protein were blocked in polio-infected cells. It is well documented that poliovirus, upon 
infection, shut down the host proteins translation machinery via the cleavage of eIF4GI 
and eIF4GII by the viral proteinase 2APRO (43).  
Poliovirus also blocks host transcription and mRNA splicing processing machinery 
through the degradation of host factors by viral proteinases 2APRO and 3CPRO in infected 
cells (43). Thus, the inhibition of these intracellular processes upon infection may explain 
the absence of ER stress response activation in polio-infected cells. Similarly, the 
activation of autophagy with a pharmacological agent also failed to stimulate the import of 
fatty acids comparable to poliovirus-infected cells. The activation of autophagy has been 
linked to the development of double membrane structures or the non-lytic release of 
infectious particles in picornaviruses-infected cells (73, 110). Therefore, it is safe to say 
that the upregulation of phospholipids observed in polio-infected cells is an infection-
specific process.  
In chapter 6, we examined the development of membranous structures and the 
replication of poliovirus in the absence or presence of PC synthesis. Newly synthesized PC 
was associated with the replication complexes and was required for the proper development 
of membranous replication structures in polio-infected cells. At high MOI, PC was 
dispensable for the production of infectious particles while at a low MOI, the infection was 
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sensitive to the inhibition of PC synthesis. We speculated that the development of 
poliovirus infection at low MOI was compromised due to a lack of membranes protecting 
the replication complexes from cytosolic sensors and therefore activating the production 
of IFN. Accordingly, we showed that monoclonal antibodies could easily access the viral 
replication complexes formed in choline-deprived cells but not those in cells incubated in 
choline-supplemented medium.  
In the future it is important to understand the mechanistic details of phospholipid 
synthesis activation upon picornavirus infection. How do the viral proteins induce rapid 
posttranslational upregulation of the cellular long chain acyl-CoA synthetase activity? Do 
different picornaviruses rely on the same or different mechanisms of lipid metabolism 
modulation? What is the major source of long chain fatty acids to sustain the phospholipid 
synthesis in infected cells – import from the extracellular medium, mobilization of neutral 
lipids from lipid droplets, or de novo synthesis by fatty acid synthase? What are the critical 
elements in the phospholipid synthesis in infected cells that can be targeted as a novel broad 
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